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Abstract 
The blood-brain barrier (BBB) is a highly selective barrier separating the brain 
from the circulatory system. The physical barrier is built up by a monolayer of 
endothelial cells, which is the main component used for in vitro modeling. To 
create more physiologically relevant in vitro models, the field of organs-on-chips 
has recently been introduced, combining microfluidics and microengineering to 
create culture environments for cells. To mimic the BBB, a continuous monolayer 
of brain endothelial cells is cultured inside these organ-on-chip devices. A step 
towards more in vivo like models is the introduction of co-cultured astrocytes, a 
brain-specific cell type in close contact with the blood-brain barrier in vivo. 
Astrocytes are reported to have a function in inducing and maintaining BBB-
specific properties of the endothelial cells. During injury to the brain, astrocytes 
become reactive, changing their function, morphology and molecular expression. 
In vitro it has been shown that the state of astrocytes is influenced by their culture 
environment. In this study, a method to incorporate hydrogels seeded with 
astrocytes in a microfluidic channel is presented, along with an investigation on 
the effect of different hydrogel compositions on astrocyte reactivity and 
morphology. Firstly, using a silane-based surface treatment a collagen type I 
hydrogel seeded with astrocytes was successfully incorporated and fixated in a 
microfluidic channel inside a polydimethylsiloxane device. Secondly, by varying 
collagen type I and hyaluronic acid concentrations, the lowest astrocyte reactivity 
was found in the hydrogels containing only collagen type I and in a mixed gel of 
collagen type I and hyaluronic acid with a low total gel concentration. A mixture 
of collagen type I and hyaluronic acid resulted in the most star-shaped astrocytes, 
characteristic morphology for astrocytes in vivo. Because of the small sample 
size, further investigation is recommended before conclusions can be drawn on 
the best hydrogel composition. The results from these two experiments were used 
to establish a co-culture system in a blood-brain barrier-chip. Unfortunately, as no 
continuous monolayer of endothelial cells was formed inside the chip and air 
bubbles inside the hydrogel structures affected the astrocyte culture, the effect of 
the presence of astrocytes cultured in a three dimensional environment could not 
be quantified. In order to achieve a reliable co-culture system optimization of chip 
design and protocol for incorporation of hydrogel is recommended.  
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Abbrevations 
AC  Alternating current  
AM  Astrocyte medium 
AJs  Adherens junctions  
APTES  (3-aminopropyl) triethoxysilane  
BBB  Blood-brain barrier  
BioMEMS  Biomedical microelectromechanical systems 
CNS  Central nervous system  
DAPI  4’,6-diamidino-2-phenylindole 
DC  Direct current 
ECM  Extracellular matrix  
EGM-2  Endothelial cell growth medium 
FITC  Fluorescein isothiocyanate 
GA  Glutaraldehyde 
GFAP  Glial fibrillary acidic protein  
GFP  Green fluorescent protein 
HA  Hyaluronic acid  
hCMEC/D3  Human cerebral microvascular endothelial cells 
HEMA  2-hydroxyethyl methacrylate 
JAMs  Junctional adhesion molecules  
NVU  Neurovascular unit  
PBS  Phosphate-buffered saline 
PDMS  Polydimethylsiloxane 
PEG  Poly(ethylene glycol)  
PEGDA  Poly(ethylene glycol) diacrylate 
PLL  Poly-L-lysine 
PVA  Polyvinyl alcohol  
RF  Radio frequency  
RFP  Red fluorescent protein 
TEER  Transendothelial electrical resistance  
TJs  Tight junctions  
UV  Ultraviolet 
VE-cadherin  Vascular endothelial cadherin  
ZO  Zonula occludens  
2D  2 dimensional 
3D  3 dimensional 
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1 Introduction 
The BBB is a highly selective physical barrier between the circulatory system and 
the brain. The substances that are able to cross this barrier are highly controlled 
by specialized endothelial cells in order to maintain the environment needed for 
the brain tissue [1]. However, this makes it problematic to develop drugs able to 
cross the barrier and reach the brain. Today, the most commonly used method for 
testing the effects of new drugs is through animal testing, also usually referred to 
as in vivo tests. In vivo models enable testing in the natural and very complex 
environment of an organ. Nevertheless, next to ethical concerns, there are several 
drawbacks of animal testing. The most important one is the large number of drugs 
that fail in a late stage of development after having shown promising results in 
animal tests, either due to poorly designed preclinical trials or difference in 
response between animals and humans [2]. Other testing methods are in vitro 
studies where the tests are carried out in cell cultures, either in a 2 dimensional 
(2D) or 3 dimensional (3D) environment. One example of a commonly used 
model for BBB research is the culturing of cells in the commercially available 
Transwell. The Transwell consists of two compartments separated by a porous 
membrane on which cells can be cultured. One of the problems with this model is 
that it is usually too simplified and is not able to incorporate natural physical 
parameters found in vivo, such as blood flow [3]. Therefore a new field of in vitro 
models has been introduced, which is called organs-on-chips. The concept of 
organs-on-chips is to combine microfluidics and bioengineering in an effort to 
faithfully replicate the smallest structure that builds up an organ, by culturing 
cells in a dynamic environment [4].  
Up to this date, there are several research groups working on developing a BBB-
on-chip [5–7]. The different models that have been published differ in design, 
material and cell lines being used, although they are all trying to replicate the 
basic structure of the BBB, which consists of brain endothelial cells [8]. In some 
models endothelial cells are co-cultured with other brain-specific cells, in an 
attempt to make the model more physiologically relevant, as some of these cells 
are capable of increasing the BBB-specific properties of the endothelial cells [9-
10]. A lot of focus has especially been put on a brain-specific cell type called 
astrocytes, which has the ability to induce BBB-specific properties in the 
endothelial cells [11]. Astrocyte function and morphology are dependent on the 
culturing method. When cultured in common plastic dishes the cells exhibit a 
state found during damage to the brain defined as reactive astrocytes, while 
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cultured in an environment better resembling the in vivo situation, for example in 
hydrogels, they adapt the non-reactive state found in healthy brain [12].   
1.1 Aim and outline 
The aim of this master thesis project is to culture astrocytes within a hydrogel 
mimicking the healthy 3D brain environment and evaluate their effect on BBB-
function when co-cultured with brain endothelial cells inside a microfluidic chip.  
To achieve this aim, three different experiments were carried out, where the goals 
of the experiments are to 
1. Functionalize the surface of the material used for the microfluidic chip, in order 
to ensure the attachment between hydrogel and channel walls. 
2. Seed astrocytes inside different hydrogel compositions and evaluate 
morphology and reactivity.   
3. Co-culture endothelial cells and astrocytes within a hydrogel in a BBB-chip 
and evaluate the effect on the barrier by measuring the barrier function.  
The results of the two first experiments are applied to the third and final 
experiment.  
In this report the BBB biology and different laboratory models mimicking the 
BBB are explained in more detail, followed by some relevant background 
information about the methods and materials used for the experiments performed. 
Afterwards, the three different experiments will be described in separate chapters 
containing methods, results and a short discussion about the used method and 
obtained results. As some of the methods are the same for all three experiments, 
these have been put in the appendix for easy reference. In the last part a general 
discussion is presented followed by conclusions and suggestions for future work.   
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2 Blood-brain barrier 
The BBB is the physical barrier that separates the brain from the body’s 
circulatory system. The purpose of the BBB is to create a highly controlled and 
selective barrier in order to maintain the specific homeostasis of the central 
nervous system (CNS), protecting the brain tissue [13]. The reason why this extra 
protection is important for the brain is the limited regenerative capability of brain 
tissue, as neurons in most cases are not capable of dividing once fully 
differentiated. Therefore, the BBB has a strict control of the transport of 
molecules such as ions, neurotransmitters, macromolecules, neurotoxins and 
nutrition that can cause harm to the cells of the brain [14]. The main structure 
building up the BBB is a monolayer of endothelial cells, which is also a 
component of the neurovascular unit (NVU). The NVU maintains and controls 
the environment of the brain and it consists of several different cell types, the 
extracellular matrix (ECM) of the brain and a special ECM for the endothelial 
cells called the basement membrane. The different constituents of the NVU 
influence the function and structure of the BBB, both in health and disease [15]. 
Modeling the BBB is of great importance for drug development and toxicology 
tests and the two most established models up to date are in vivo tests, carried out 
in animal models, and in vitro tests in Transwell models [16]. The disadvantages 
of these models have led to a need for new and more reliable ones, and within the 
field of organs-on-chips researchers are trying to create models capable of 
meeting these needs. The main idea is to incorporate microchannels in materials 
such as glass or polydimethylsiloxane (PDMS) where cell cultures, either grown 
directly on the material of the channel or incorporated in hydrogels, are exposed 
to a fluidic flow [17]. For evaluation of the cell barrier in in vitro models of the 
BBB there are two commonly used measurement methods: permeability tests and 
resistance measurements carried out across the cell layer, referred to as 
transendothelial electrical resistance (TEER) measurements [18].   
2.1 Neurovascular unit 
The NVU consists of endothelial cells that form the BBB, a basement membrane, 
pericytes, astrocytes, neurons, microglia and the ECM of the brain [15]. A full 
overview of the NVU and its components can be seen in Figure 1. The main 
function of the NVU is to control the exchange of fluids and molecules between 
the brain and the blood in order to maintain an optimal environment for the brain. 
This is achieved by controlling the permeability across the barrier [19]. It is worth 
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noting that it is still unclear exactly how each of the components contribute to the 
specific properties of the BBB [13].  
 
Figure 1. A schematic of the NVU. Embedded in the ECM of the brain neurons, astrocytes, 
microglial cells and pericytes are present while endothelial cells, lined with the basement 
membrane, make up the barrier separating brain and blood. Reprinted from [20]. 
 
2.1.1 Endothelial cells 
The main component that contributes to the specific properties of the BBB is 
cerebral endothelial cells. These cells are ordered in a monolayer and together 
with the basement membrane they create the wall of the capillaries, which makes 
them the main physical barrier between the brain and the circulatory system [11]. 
Endothelial cells line blood vessels in all organs, allowing them to control the 
exchange of substrates between the blood and the organ [21]. The main difference 
between brain endothelial cell-layers and endothelial cell-layers in other parts of 
the body is that the connections between the cerebral endothelial cells are 
typically 50-100 times tighter. This leads to a lower degree of transport between 
the cells (paracellular transport), meaning that the main way of transport between 
the blood and the brain is through well-regulated transcellular transport [11,15]. 
These tight connections between cells are established by two main groups of 
protein complexes called tight junctions (TJs) and adherens junctions (AJs). In 
addition, the cerebral endothelial cells have more BBB-specific properties that 
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contribute to the selective barrier that differs from other endothelium. Some of 
these properties are the absence of fenestrae (small pores in endothelial cells that 
allow for rapid molecular exchange), a low pinocytotic activity (uptake of 
extracellular fluid into the cell by endocytosis) and a high concentration of 
mitochondria, meaning that the cells can have a higher metabolic activity [22]. 
The specific properties of the endothelial cells and the high concentration of tight 
junctions lead to the highly controlled transcellular and paracellular transport, 
causing the transport pathways across the barrier to be limited to only specific 
molecules and compounds. In Figure 2 the different transport pathways across the 
barrier are shown. The degree of permeability across the BBB depends on the 
integrity of the barrier. Tighter connected endothelial cells will cause less 
compounds to cross the cell layer via the paracellular pathway [14]. 
 
Figure 2. The different transport pathways across the BBB. In pathway a water-soluble agents are 
capable of crossing through paracellular pathways, while in pathways b-e transport is through 
transcellular pathways. In b lipid-soluble agents are capable of crossing the cell membrane through 
the transcellular lipophilic pathway. In c transport proteins will transfer compounds such as glucose 
and amino acids across the cell barrier. In d and e transport across the endothelial cells is carried out 
through transcytosis, either receptor-mediated (d) or through adsorption (e). Reprinted from [1].   
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Tight junctions 
One of the main contributors to the strong connection between the endothelial 
cells within the BBB are TJs. The TJs are built up by three main groups of 
transmembrane molecules connecting the endothelial cells. The two groups 
responsible for cell-cell interaction are called occludins and claudins, while the 
third group, called junctional adhesion molecules (JAMs), is responsible for 
organizing the structure of the TJs. All protein groups and their positions in the 
cell membrane can be seen in Figure 3. Occludin and claudin proteins are 
connected to the cytoskeleton of the cells through zonula occludens (ZO) 
proteins, a group of proteins positioned in the cytoplasm of the cell close to the 
membrane [23]. Occludin was the first tight junction protein to be discovered, 
although experiments with occludin-deficient mice showed no distinct difference 
in BBB function compared to wild-type mice [24]. These results indicate that 
occludin is not necessary for the formation of the TJs, but instead may act as an 
extra support structure [15]. The second protein group is the claudin family, and 
these proteins are reported to give rise to the specific characteristics of the barrier 
tightness and restricted paracellular diffusion [23]. In experiments with claudin-5-
deficient mice it was shown that the size-selectivity for smaller molecules across 
the barrier decreased, indicating the importance of these proteins when it comes to 
the permeability of the barrier [25]. The third family of proteins present at the 
TJs, JAMs, are thought to have a role in organizing the structure of the TJs as 
well as controlling the movements of immune cells across the barrier [23]. The 
degree of TJs present between the cells will have a large influence on the 
tightness of the barrier: the more TJs present, the tighter the connection between 
the cells [26]. 
Adherens junctions 
The AJs are positioned just basal to the tight junctions (see Figure 3). The main 
AJ protein is a transmembrane protein called vascular endothelial cadherin (VE-
cadherin) that together with another group of proteins called catenins forms 
complexes that provide cell attachment and structural integrity between the 
endothelial cells. Due to this, the presence of AJs is important for the formation of 
TJs [14].  
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Figure 3. An illustration of the connections between endothelial cells. The TJs make up the main 
connection between the cells and consist of three types of transmembrane molecules: occludins, 
claudins and JAMs. These are connected to actin filaments via ZO proteins. The AJs are positioned 
basal to the TJs. Reprinted from [14] 
 
2.1.2 Basement membrane 
The basement membrane is a 50 - 100 nm thick layer of specialized ECM, which 
can be found close to monolayers of cells, such as endothelium and epithelium, 
separating them from the surrounding tissue. The main components of the 
basement membrane are collagen type IV, laminin, perlecan and nidogen. In 
addition there are several other minor components present with varying 
concentrations depending on the organ [27]. Within the NVU the basement 
membrane is situated between the endothelial cells and the astrocytic endfeet, 
providing stability for the cells and controlling cell processes and signaling 
between cells with its ECM components [28]. 
2.1.3 Pericytes 
Pericytes are embedded within the basement membrane and enclose part of the 
surface of the cerebral endothelial cells through cytoplasmic extensions. The 
pericytes are reported to have an important role when it comes to blood vessel 
stabilization, angiogenesis (formation of new blood vessels), blood flow 
regulation and maintenance of BBB properties [29]. Pericytes are capable of 
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affecting the BBB properties by altering the permeability over the barrier and the 
integrity of the TJs [15].   
2.1.4 Astrocytes 
Astrocytes are a cell type specific for the CNS and they are situated in close 
contact with neurons and blood vessels within the CNS. Some of the known 
functions of astrocytes are providing physical support, taking up and excreting 
compounds from and to endothelial cells and neurons, maintaining homeostasis of 
the brain and inducing BBB specific characteristics of the endothelial cells [30]. 
Astrocytes have a spherical cell body with long and thin processes, resulting in a 
star-shaped morphology, that are connected to neurons and endothelial cells 
through their endfeet. These connections are of great importance for uptake and 
excretion of molecules between the cells. For example at the contact points with 
blood vessels astrocytes take up glucose and water and transfer these to neurons, 
and through neuron-controlled signaling they excrete molecules regulating 
dilation and contraction of the vessels. Another function is to induce BBB 
properties in endothelial cells, although it is still unclear how this is achieved 
[30].  
During damage to the CNS astrocytes respond by changing from a non-reactive 
state to a reactive state. The reactive state is characterized by an increased cell 
volume as well as an increase in the number of cells. It has been shown that 
during the reactive state astrocytes upregulate their expression of several 
molecules such as growth factors, cytokines, enzymes and intermediate filaments, 
such as glial fibrillary acidic protein (GFAP) [31]. Depending on the damage, the 
presence of different agents will trigger an activation of the astrocytes. In Figure 4 
agents that trigger an activation of astrocytes are shown as well as the cause for 
their presence. 
One of the most common markers used for identifying astrocytes from other cell 
types is GFAP, mainly present in astrocytes. GFAP is a part of the cytoskeleton of 
the astrocytes and the main function is to define and maintain the star-shape that 
is typical for astrocytes [32]. While low levels of GFAP are expressed in most 
astrocytes during their non-reactive state, there is an upregulation of GFAP 
expression when reactive [31].  
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Figure 4. A schematic of molecular interactions with an astrocyte. Agents related to brain injuries 
will trigger the activation of astrocytes, leading to hypertrophy, molecular changes and functional 
changes of the cell. Reprinted from [30].   
 
2.1.5 Neurons 
Neurons can either be directly connected to blood vessels or indirectly via 
astrocytes [33]. The role of neurons for the BBB properties is still not fully 
understood, although it is thought that they regulate some functions of the barrier 
[13]. One example of this is that neurons are capable of influencing the blood 
flow in order to meet their metabolic needs. This mechanism is referred to as 
neurovascular coupling, and through neurotransmitter-based signaling neurons 
can either directly or indirectly, in that case through astrocytes, regulate the 
cerebral blood flow [34].   
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2.1.6 Microglia 
Microglial cells are situated within the CNS and function as an immune defense 
for the brain. The microglia can either be in a resting or activated state and will 
have different morphology depending on the state. In the resting state, which 
occurs in healthy brain tissue, the cell has a small body with long and thin 
processes, which it uses to survey the tissue for potential threats. In the activated 
state the long processes are lost and a shape similar to phagocytes, an important 
cell for the immune response, is adopted. This state occurs in the presence of 
pathology to the CNS [35-36]. There are several studies indicating that during the 
active state of the microglia cells they excrete inflammatory factors causing 
disruption of the BBB, associated with neurodegenerative diseases such as 
Alzheimer’s disease [37].  
2.1.7 Extracellular matrix of the brain 
The ECM of the brain differs in its composition when compared to the ECM of 
other tissues. The common ECM components in the rest of the body, such as 
collagen and fibronectin, are only present in very low concentrations in the brain 
ECM [38]. Instead, the ECM of the brain has been shown to mainly contain 
compounds such as proteoglycans, containing binding sites for the polysaccharide 
hyaluronic acid (HA), and the ECM protein tenascin [39]. Due to the high density 
of cells within the brain tissue, only about 20% of the total brain volume is 
extracellular space, meaning that the degree of ECM in the brain is very low 
compared to other tissues [40].  
2.2 BBB modeling 
For a better understanding of neurovascular diseases and the effects of new drugs 
on the BBB, reliable models for testing are needed. The mainly used models for 
BBB research are in vivo and in vitro models. Two examples of in vitro models 
used for BBB research are the Transwell setup and BBB-on-chip. As the cells in 
in vitro BBB-models are not exposed to their natural environment there is a need 
for measurement methods to evaluate the reliability of these models as well as to 
measure the experimental conditions investigated. For BBB-models the main 
focus is on the integrity of the barrier, and the two most commonly used methods 
to evaluate the barrier is through permeability tests and TEER measurements.  
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2.2.1 In vivo models 
The method that gives the best results for testing effects of drugs and to get a 
better understanding of diseases are studies performed directly in humans. 
However, for ethical reasons this is not a possibility. Therefore most in vivo tests 
for new drugs are carried out in animal models [2]. The main advantage of using 
animal models is that it is possible to study the BBB in its natural environment. 
However, the numerous disadvantages such as slow and costly experiments and 
their ethically questionable character has lead to a search for other methods [41]. 
Furthermore, there are several examples of poor translation between the results 
obtained in animals compared to humans, causing a lot of new drugs to fail in a 
late stage of development. This can be the result of poorly designed and executed 
studies as well as the fact that animal models are not able to completely predict 
the human response as there are differences when it comes to molecular and 
metabolic pathways between species [42-43].  
2.2.2 In vitro models 
The in vitro models are based on biological components such as cells and 
microorganisms that have been taken out of their natural environment. The most 
established in vitro model for BBB research is a static 2D monolayer model, 
where a commonly used setup is the Transwell. However, there are new models 
being developed in order to meet the short-comings of the Transwell. One such 
example is the BBB-on-chip, where the cells are exposed to a dynamic 
environment [44].  
Transwell  
One of the most commonly used setups for in vitro modeling of the BBB is the 
Transwell. The Transwell consists of a well with a removable insert containing a 
porous membrane on which cells can be grown [45]. The membrane is typically 
10 µm thick and can be made of different materials such as polycarbonate or 
polystyrene [2]. This model allows for mono-, co- and tri-culturing of cell types in 
each well, and easy handling makes it possible to perform high-throughput assays 
in this system [46]. A commonly used co-culturing model contains endothelial 
cells on the luminal side of the membrane and astrocytes on the abluminal side, 
and the setup can be seen in Figure 5 [47]. Even though this model is sufficient 
for some studies, for other studies it can be too simplified in order to be a reliable 
model. Another dilemma is that the environment that the cells are grown in is 
static [46]. In vivo, endothelial cells in the brain capillaries are exposed to shear 
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stresses between 0.3-2 Pa, which trigger responses from the cells, affecting barrier 
integrity and permeability across it [8,48].  
 
Figure 5. An example of a co-culture system in a Transwell model. Endothelial cells are cultured 
on the porous membrane on the inside of the insert while astrocytes are grown on the outside of the 
insert. Reprinted from [49].  
 
Organs-on-chips 
Organs-on-chip is a research field where microengineering, cell culturing and 
microfluidics are combined in order to create a new in vitro model for research. 
Some of the drawbacks with the currently used in vitro models based on 2D or 3D 
cell culturing are the difficulties to adapt the microenvironment for the cells and 
to implement different physical parameters, such as compression and shear stress 
[50]. With the use of microfluidics and microengineering in organs-on-chips 
models, these problems have been addressed. Up to date several different chips 
for several different organs have been developed, such as lung-on-a-chip [51], 
gut-on-a-chip [52] and BBB-on-a-chip [7]. An example of a BBB-on-chip is 
shown in Figure 6.   
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Figure 6. An example of a BBB-chip. In A a schematic of the design is showed, where 1 is the top 
part of the chip with a channel and holes for the inlets and outlets of the channels. 2 is the membrane 
separating the two channels and 3 is the bottom part of the chip with a channel oriented 
perpendicular to the top channel. 4 shows two electrodes connected to each of the channels. In B an 
image of the assembled chip is shown. Reprinted from [53].  
 
In the BBB-on-chip models, a monolayer of endothelial cells is cultured under 
flow. In some models the endothelial cells are co-cultured with other cells from 
the NVU such as astrocytes, pericytes or neurons [8].   
2.2.3 Transendothelial electrical resistance measurement 
A commonly used method for assessing the tightness of a cell layer is by 
measuring the electrical resistance across a cell barrier grown on a semipermeable 
membrane, where the resistance across endothelial or epithelial cell layers is 
referred to as TEER. The method is based on measuring the resistance of the 
barrier to charged ions or molecules across the barrier. A higher measured 
resistance means that there is a lower amount of charged compounds capable of 
crossing the barrier [54]. The electrical resistance across the pial arteries (blood 
vessels covering the surface of the brain) in vivo has been measured to lie 
between 1500-2000 Ω cm2, compared to 3-33 Ω cm2 for similar endothelia in 
other tissues [55].  
TEER measurement is a non-invasive method allowing measurements of the 
integrity of the barrier in real-time with the use of electrodes [15]. During a TEER 
measurement the transcellular and paracellular ion flux over the cell barrier is 
measured. The resistance of the barrier is either characterized by the direct current 
(DC) or single frequency alternating current (AC) method, or through impedance 
spectroscopy. During impedance spectroscopy an AC signal is applied over a 
A B 
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frequency span and the amplitude and phase shift of the recorded current are 
measured [54].  
To calculate the resistance from a DC or single frequency AC measurement 
Ohm’s law is applied. With an applied voltage V (in V) on two electrodes 
positioned on each side of the barrier, the resulting current I (in A) is measured 
and the resistance R (in Ω) can be calculated according to equation 1. 
  
 
 
   (1) 
To extract the TEER value a blank measurement of the membrane that the cells 
are to be grown on is carried out (RBlank). The resistance of the membrane will be 
subtracted from the resistance obtained from the measurements on the monolayer 
grown on the membrane (RTotal) [54]. The resulting resistance RCellLayer is inversely 
proportional to the area of the monolayer (AMemb) and in order to normalize the 
TEER to Ωcm2, resistance is multiplied with area [56]. The full calculations are 
shown in equations 2 and 3.    
                         
 
     
   (2)
  
                        (3) 
For an impedance measurement the full system consisting of the cell barrier, 
electrodes and culture medium is modeled as an electrical circuit. Within this 
model the paracellular pathway, influenced by TJs between cells, are modeled as 
a resistor (TEER) and the transcellular pathway across the cells are modeled as a 
parallel circuit of a capacitor and a resistor, representing the cell membrane. In the 
measurements culture medium and electrodes will also have an effect on the read-
out, and the medium can be modeled as a resistor and the electrode-medium 
interface as a capacitor [57]. A schematic of the representative electrical circuit 
can be seen in Figure 7.  
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Figure 7. A representative circuit of an endothelial cell layer. The TEER representing the 
paracellular transport across the barrier is modeled as a resistor, while the transcellular transport is 
modeled as a parallel circuit of a resistor, Rmembrane representing the cell membrane, and a capacitor, 
CCl representing the cell layer. The culture medium is modeled as a resistor, Rmedium, and the 
electrode-medium interface as a capacitor, CEl. Reprinted from [57].  
 
An example of an impedance spectrum can be seen in Figure 8. In Figure 8B a 
simplified circuit compared to the one shown in Figure 7 is seen. This 
simplification can be performed for the frequencies used for TEER 
measurements, as for this range the high resistance of the cell membrane will 
cause the current to mainly go through the capacitance representing the cell layer. 
For mid-range frequencies values the main contributors to the measured 
impedance are the TEER from paracellular pathways and the capacitance from the 
cells, and from this value the TEER can be extracted. Also in the case of an 
impedance spectroscopy a measurement from an empty membrane is needed and 
the resulting TEER value is normalized to the area [57]. Compared to a single 
frequency AC measurement the impedance spectroscopy is more accurate and 
sensitive in its measurements of the barrier integrity [58].    
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Figure 8. Schematic of an impedance spectra (A) together with a simplified electrical circuit of 
the endothelial cell monolayer (B). For different frequencies different components will affect the 
impedance the most. Low frequencies – capacitance of electrode and medium interface, middle-
range frequencies – cell layer and for high frequencies – medium. Reprinted from [57]. 
 
2.2.4 Permeability assay 
As one of the defining characteristics of the BBB is the highly selective transport 
across the barrier, a common method to evaluate its integrity is by measuring the 
permeability of certain compounds across the barrier. In particular hydrophilic 
compounds have very restricted pathways across the barrier, and they either need 
to cross by specific transport proteins or through the paracellular pathways [59]. 
Therefore, hydrophilic compounds, typically labeled with fluorescent or isotope 
tracers, are often used for permeability assays. Commonly used molecules for 
permeability assays of the BBB are fluorescein isothiocyanate (FITC)-dextrans of 
different sizes [60]. These molecules are visualized with a fluorescent microscope 
in order to measure if they are capable of crossing the barrier, and the different 
sizes of the molecules are used to assess how tightly connected the cells are and to 
test the size-selectivity of the barrier, as the larger the molecule, the lower the 
chance is for it to cross the barrier [47].  
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3 Experimental background 
In this chapter, some background information is included about the materials and 
methods used for the experiments described in the next chapters to help 
understanding the report. The chip design used is explained, followed by the 
characteristics of hydrogels and cell lines used for the experiments.  
3.1 Chip design 
The chip, previously developed at the BIOS Lab on a Chip group, consists of two 
connected PDMS parts, one top and one bottom, with a microchannel in each. At 
the crossing of the two channels a porous polycarbonate membrane is positioned, 
separating the channels.  In connection to the channels from the edges of the chip 
are electrode channels where platinum electrodes are inserted, with a part of the 
electrode positioned in the fluid channel. The full design of the chip together with 
dimensions can be seen in Figure 9 [61]. 
 
Figure 9. A schematic of the chip design (A) and an image of the assembled chip (B). In A the 
different parts and dimensions are presented. The chip consists of a top part containing a channel 
(TC) and holes for inlets and outlets of the channels. In the bottom part there is a channel 
perpendicular to the top channel (BC). Separating the two channels is a membrane (M) and four 
electrodes are incorporated, two in each channel (E1-E4). Reprinted from [61].  
 
3.1.1 PDMS 
PDMS is an elastic polymer, commonly used for the production of biomedical 
microelectromechanical systems (BioMEMS), such as lab-on-a-chip and organs-
on-chip. In most of the published BBB-on-chips, PDMS is the main component 
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used for chip fabrication [7, 53, 62]. The reason why PDMS is so extensively 
applied within this field is due to the fact that it is chemically inert, transparent, 
biocompatible, gas permeable, thermally stable, cheap and easy to handle [63].  
Despite the large number of advantages using PDMS for these devices, the highly 
hydrophobic nature of the material can be a drawback, since interactions between 
the channel surface and the liquid used to create an aqueous environment for the 
cells will be low. This can be problematic during the filling of a chip with an 
aqueous liquid or when incorporating a hydrogel in the channel, causing 
detachment of the gel from the channel surface. Therefore, methods to increase 
the hydrophilicity and to incorporate reactive groups on the surface are desired 
[64]. The most commonly used method to achieve this is through plasma 
treatment. However, the hydrophilicity is short-lived, as the material resumes its 
hydrophobic state within a few minutes [65]. To create a more long-lasting effect 
different chemical surface treatments have been proposed in order to functionalize 
the PDMS, where some examples are polyvinyl alcohol (PVA), poly(ethylene 
glycol) (PEG) and (3-aminopropyl) triethoxysilane (APTES) treatments [67–69]. 
In the following sections the three different surface treatments used in the 
experiments are explained.   
Plasma oxidation 
One method to increase the hydrophilicity of a PDMS surface is by oxidizing it, 
using plasma. This treatment will create hydroxyl groups on the surface, 
increasing the wettability of the surface. This is a short-lived surface 
functionalization, and the hydrophobicity will be restored [65].  
Poly-L-lysine coating  
Poly-L-lysine (PLL) is a positively charged polyelectrolyte. When a PDMS 
surface is oxidized with plasma it will become negatively charged, causing the 
PLL to adsorb to the surface [69].   
APTES and glutaraldehyde treatment 
For a more long-lasting treatment of PDMS a chemical treatment can be carried 
out. One method is through binding of APTES and glutaraldehyde (GA) to the 
PDMS surface, which will interact and covalently bond to proteins such as 
collagen. After oxidizing the PDMS surface the hydroxyl-groups will interact 
with the APTES, which will cross-link with the GA and in the final step create a 
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covalent bond to the protein [70]. A schematic of the treatment can be seen in 
Figure 10. 
 
Figure 10. A schematic of the chemical treatment of a PDMS surface with APTES and GA, 
covalently binding to proteins. Reprinted from [70].  
 
 
3.2 Hydrogels 
Even though the standard procedure for cell culturing is on a 2D surface, 
experimental evidence shows that cells cultured on a 2D surface exhibit atypical 
behaviors when compared to the same cells in vivo [71]. Therefore there is an 
increased desire for in vitro culturing of cells in a 3D environment that resembles 
the natural environment of the cells. One promising type of material for creating 
these 3D environments is hydrogels, which are highly hydrated, cross-linked 
polymers [72]. These networks are capable of mimicking the ECM and can be 
made out of different materials. Typically the different polymers can be divided 
into two groups: synthetic polymers or natural polymers, depending on their 
origin. Some natural polymers used as hydrogels are collagen, HA and Matrigel 
and examples of synthetic polymers are 2-hydroxyethyl methacrylate (HEMA) 
and PEG [73].  
In this project two different hydrogels were used. Further details about these are 
described below. 
3.2.1 Collagen type I 
Collagen type I is one of the most abundant proteins in the ECM of humans and is 
commonly used as a natural polymer for hydrogels [74]. Collagen consists of 
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three amino acid chains that are arranged in a triple helical structure and assemble 
into fibrils and further into collagen fibers [75].  
Collagen type I is one of the most commonly used hydrogels for culturing cells in 
BBB-models and it is mainly glial cells, such as astrocytes, and neuronal cells that 
are cultured within the gel [9]. Despite the fact that collagen type I is not a natural 
component of the ECM of the healthy brain, it is still widely used due to its strong 
cell adhesion and physical strength. In brain modeling it can be used to offer the 
support otherwise provided by neurons [76-77]. The collagen gels are typically 
stored in an acidic environment at 4
ᵒ
C, as they start to gel (meaning that the gel 
will go from liquid to semisolid) at a neutral pH or at room temperature [76].  
Collagen is a natural protein and therefore typically extracted from animals. This 
will lead to a lower control of the reproducibility of the structure and mechanical 
properties of the gel, as well as batch to batch differences [78].  
3.2.2 Hyaluronic acid 
HA, also referred to as hyaluronan, is a polysaccharide with a repeating unit of N-
acetyl-D-glucosamine and glucoronic acid, and it can be found in the ECM 
throughout the whole human body, with the highest concentrations in soft 
connective tissue [79]. It is also one of the most abundant components of the 
ECM of the brain, together with proteoglycans and tenascins [39]. 
HA can be chemically modified to form hydrogels by addition of compounds to 
the functional groups of the chains, where some examples are thiols, aldehydes 
and haloacetate [80]. These hydrogels have a lot of different biomedical 
applications such as tissue engineering, drug delivery and cell culturing [76, 78, 
80]. For cell culturing of brain specific cell types such as astrocytes, HA have 
been used to mimic the natural ECM of the brain [77]. 
3.3 Cells 
Cells used for culturing can either be from immortalized cell lines, which are cell 
cultures from one original cell, primary cells, which are cells isolated from the 
body, or human induced pluripotent stem cells, adult cells that has been converted 
into pluripotent stem cells. The cells can be obtained from different sources such 
as pig, rat, cow and human. For BBB research a lot of different cell lines are 
available and they exhibit different properties, making some cell lines more 
suitable for certain studies than others. The cell lines used for the study explained 
in this report are explained in further detail in the following sections.  
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3.3.1 hCMEC/D3 
The human cerebral microvascular endothelial cells hCMEC/D3 are a cell line of 
primary endothelial cells, obtained from the brain, which has been immortalized 
(kindly provided by Dr. P.-O. Couraud, INSERM, Paris, France) [82]. This allows 
the cells to maintain the BBB specific properties of cerebral endothelial cells as 
well as increased survival in an in vitro environment. The hCMEC/D3 cell lines 
typically express cerebral endothelial cell morphology and tight junction markers 
such as ZO. However, the TEER values are on average 40 Ωcm2 in standard 
cultures, which is significantly lower than in vivo values of more than 1000 Ωcm2. 
When co-cultured with other cell types the TEER value is either slightly 
increased, with astrocytes, or not affected at all, with pericytes [49].     
3.3.2 Primary human astrocytes 
Primary human astrocytes are isolated from the human brain. For the cells used in 
the experiment presented in this report they are specifically from the cerebral 
cortex (ScienCell, Catalog 1800). The cells are isolated from a brain sample and 
purified for astrocytes by removing the other cell types present in the brain 
sample [83]. For primary cell cultures the same function and expression of the 
cell type in vivo is obtained. However, the main limitation of these cells are their 
low doubling capacity, meaning that they can only be used for lower passage 
numbers (for the cells used in this experiment a passage number below 10 was 
always used) [84]. 
3.4 Measurement methods 
In order to characterize the outcome of each experiment two different methods 
were used. In all experiments the cells were stained in order to evaluate 
morphology, viability and expression and in the final experiment a TEER 
measurement was performed to evaluate the barrier integrity of the endothelial 
cells. 
3.4.1 Staining 
Visualization of cells through the addition of fluorescent compounds is one of the 
most important methods to evaluate structure and function of cells [85]. There is a 
wide range of different stainings that will stain different structures of the cell, 
where some examples are the nucleus, cytoskeleton and membrane. For the 
experiments presented in this report staining of nucleus, actin filaments and 
GFAP were performed.  
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For staining of the nucleus NucBlue was used. NucBlue contains the label 
Hoechst 33342, a compound with high membrane permeability that emits 
fluorescent light at a wavelength of 460 nm (blue) when bound to DNA 
(Invitrogen). Staining of the nucleus was performed for detection and counting of 
cells.  
To visualize the morphology of cells actin filaments, which makes out part of the 
cytoskeleton of cells, are targeted. Two different actin stainings were used for the 
experiments, ActinGreen and Texas red-X Phalloidin. Both stainings contain a 
probe with high affinity for actin filaments that has been combined with a 
fluorescent dye. ActinGreen contains the green fluorescent dye Alexa Fluor 488 
and Texas red-X Phalloidin contains the red fluorescent dye Texas red 
(Invitrogen).  
Staining of GFAP requires indirect staining with antibodies. For indirect antibody 
staining a primary antibody, commonly produced in an animal such as rat or 
mouse, is added that binds specifically to the desired antigen, in this case GFAP. 
Afterwards, a secondary antibody labeled with a fluorescent dye, directed against 
the primary antibody, will be applied to the sample. Important for the secondary 
antibody is that it has to be produced in another animal, against the first animal 
[86]. For the experiments presented in this report rat anti-GFAP was used as 
primary antibody and either goat anti-rat IgG Alexa Fluor 568 or 488 as 
secondary antibody.       
3.4.2 TEER setup 
The TEER was measured using a model designed and fabricated in-house 
(commercialized as Boxense by LocSence, Enschede, the Netherlands) and the 
setup can be seen in Figure 11. A laptop containing a Labview program written 
in-house operates a lock-in amplifier. The amplifier is connected by two clamps 
to the electrodes of the chips (Figure 12). A total of six measurements for six 
different connection combinations to the platinum electrodes are performed for 
each chip. The impedance spectroscopy was screened over frequencies between 
200 Hz-1 MHz in 100 steps.  
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Figure 11. Image of setup used for TEER 
measurements. In the image a black lock-in 
amplifier box containing a signal generator and 
measurement equipment, a computer with the 
Labview program and a probe with an additional 
amplifier circuit connected to the chip with two 
clamps are shown. 
 
 
Figure 12. Zoom in of the chip and its 
connection with the probe. In the image the 
clamps are attached to two of the electrodes. 
From the measurements the bode plots together with raw data containing output 
voltage, phase shift and input voltage for each connection can be extracted and is 
loaded into a Matlab script [87]. The channels filled with medium and the 
membrane with cells can be represented by resistors, shown schematically in 
Figure 13. From the raw data the impedance of each connection is calculated 
resulting in the formation of six linear equations, one for each connection. By 
solving these equations the membrane resistance is obtained (see equations 4-10) 
[87].   
 
 
Figure 13. Simplified electrical circuit of the chip. The top channel (TC), connected to electrode 1 
and 3 (E1 and E3), is represented by the resistors R1 and R3 and bottom channel (BC), connected 
to electrode 2 and 4 (E2 and E4), is represented by the resistors R2 and R4. The membrane (M) 
together with the endothelial cell layer (EC) is represented by one resistor (Rm). Reprinted from 
[61].    
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                 (4) 
                 (5) 
                   (6)  
                   (7) 
                   (8) 
                   (9) 
These six equations can be summarized into the following equation for Rm: 
                                     (10) 
where Rm is the total resistance of the cell layer and the membrane [87]. For the 
hCMEC/D3 cell line there will be a high paracellular transport, making the 
transcellular transport negligible. Therefore, to obtain the TEER from the total 
resistance only the resistance of the membrane, measured on the blank chip, needs 
to be subtracted. Finally, the resulting resistance value is normalized to the 
surface area, as explained in section 2.2.3. 
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4 Experiment 1: Surface functionalization  
The hydrophobic nature of PDMS makes it a problematic material to use when 
working with hydrogels, due their high water content. With low interaction 
between gel and channel wall, the risk of gel contraction and failure of the 
structure increases when external forces such as fluid flow and internal forces 
from cells are added. To increase the interaction between the hydrogels and 
PDMS channels, three different surface treatments of the channels have been 
evaluated. 
4.1 Materials and methods 
For the experiment a total of 8 chips were used to evaluate three different surface 
treatments. A simplified design of the PDMS chip explained in section 3.1 with a 
single channel connected to a PDMS-coated glass cover slip, seen in Figure 14, 
was used (for method see appendix A. Chip fabrication). The three different 
surface treatments evaluated are: plasma oxidation, PLL coating and a chemical 
treatment with APTES and GA. Untreated chips were used as control. The 
protocols for the different treatments are described in the sections below.  
 
Figure 14. Image of the chip design where a single-channel PDMS chip 
has been plasma bonded to a glass cover slip coated with a thin layer of 
PDMS. 
 
To functionalize the surface of the PDMS channel with plasma oxidation three 
chips were plasma oxidized at a low radio frequency (RF) setting for 40 s (Plasma 
cleaner/sterilizer, Harricks). After the plasma treatment two of the chips were 
stored at 4
ᵒ
C for 3 h before adding the hydrogel, and the third chip was filled with 
the gel directly after it had been treated with plasma. 
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To add a coating of PLL to the surface of the channel one chip was plasma treated 
at a low RF setting for 40 s and directly after filled with a PLL solution of 1 
mg/ml (ScienCell Research Laboratories). The chip was incubated at room 
temperature for 2 h and afterwards the solution was aspirated. Prior to adding the 
hydrogel, the channels were rinsed with sterile purified water. Inspired by 
protocol from [88]. 
For the chemical treatment of the PDMS surface a 3% APTES (Sigma Aldrich) 
solution in MilliQ (Purelab Flex) was pipetted into the channels of two chips, 
which were left to incubate at room temperature in the solution for 30 min. 
Afterwards they were rinsed in 99% ethanol (Boom) and left to incubate in 
ethanol at room temperature for another 30 min. Once more the chips were rinsed 
with ethanol and then dried with an air blow gun. In the final step a 20% GA 
(Sigma Aldrich) solution in phosphate-buffered saline (PBS) was pipetted into the 
channels and left in the solution to incubate at room temperature for 30 min. After 
the final incubation step the chips were rinsed with purified water and dried with 
an air blow gun. The chips were stored at 60
ᵒ
C over-night. Based on protocol 
from [70]. 
For the hydrogel a collagen type I concentration of 3 mg/ml and an astrocyte 
concentration of 5.5
.
10
6
 cells/ml at a passage number of 7 were used in all chips 
(for method on cell culturing see appendix A. Cell culturing). 
To neutralize and dilute the collagen type I stock 10X PBS and 1 M NaOH 
(Sigma Aldrich) were added to an Eppendorf tube and put on ice. Astrocyte 
medium (AM: Lonza) containing the cells to be seeded in the gel was added to the 
tube and in the final step the collagen type I (Corning) was added (concentrations 
and volumes used are found in appendix A. Hydrogels). The liquid gel was mixed 
thoroughly through pipetting and then added to the channels. The chips were left 
in an incubator at 37
ᵒ
C for 30 min to be sure of complete gelling before adding 
fresh AM. The medium was changed by inserting a pipette tip in the inlet 
containing 150 µl and another pipette tip in the outlet containing 100 µl. The 
hydrostatic pressure difference between the pipette tips ensures a slow flow rate 
of fresh culture medium through the channel. Medium was changed twice per 
day, once in the morning and once in the afternoon, during the 48 h duration of 
the experiment. Images were taken at 24 h and 48 h with a phase contrast 
microscope (EVOS FL Cell Imaging System).    
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As a final step the cells were fixated and stained with ActinGreen and NucBlue 
and imaged using a fluorescent and confocal microscope (Nikon Confocal A1). 
For protocol of staining see appendix A. Staining of cells and for more 
information about microscopy see appendix A. Microscopy.  
4.2 Results and discussion 
Out of the eight chips that were filled with cell-seeded hydrogels, one of the glass 
cover slips broke when adding the hydrogel and was not used further. After 24 h, 
in three of the chips the gel was for the most part attached to the walls and in the 
other four chips the gel had detached from the walls. After 48 h of the experiment 
only in one of the chips the gel was still attached to the channel walls and in the 
other two the gel had detached. A summary of these results can be seen in Table 1 
and images showing examples of gels attached and detached from the walls can 
be seen in Figure 15 and 16.  
Table 1. Table summarizing the outcome of each chip with different surface treatments at the two 
different time frames of the experiment, 24 h and 48 h. A-gel attached, D-gel detached, X-damage 
to chip and S-staining. 
 No surface 
treatment 
APTES + 
GA 
Plasma 
oxidation, 
stored 4ᵒC 
Plasma 
oxidation 
PLL 
coating 
Chip 
number 
1 2 3 4 5 6 7 8 
24 h A D A X A D D D 
48 h D - S - D - - - 
 
 
Figure 15. Image of chip 3 at 24 h showing a 
gel attached to the channel walls. Taken with 
phase contrast microscope with a scale bar of 
1000 µm.  
 
Figure 16. Image of chip 2 at 24 h showing a 
gel detached from the channel walls. Taken with 
phase contrast microscope with a scale bar of 
1000 µm. 
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For the chip chemically treated with APTES and GA the gel was still fully 
attached to the walls after 48 h. This chip was used for staining and viable cells 
with characteristic morphology of astrocytes could be seen (Figure 17 and 18). 
 
Figure 17. Image from chip 3, treated with 
APTES and GA, showing astrocytes distributed 
in the gel inside the channel. The cells were 
stained with NucBlue and ActinGreen and 
imaged with GFP and DAPI filter cubes. Scale 
bar is 200 µm.  
 
Figure 18. Image from chip 3 with higher 
magnification showing star-shaped astrocytes. 
The cells were stained with NucBlue and 
ActinGreen and imaged with GFP and DAPI 
filter cubes. Scale bar is 200 µm. 
 
With confocal microscopy it was possible to see that the gel was attached to the 
channel walls in its full height and that the cells were spread throughout the gel, 
as seen in Figure 19 and 20. In Figure 20 the height of the gel is seen, where the 
intensity of the cells is higher on the left side (bottom of gel) compared to the 
right side (top of gel). This is due to the confocal microscope where the excitation 
laser is placed underneath the sample, causing a lower intensity from the cells 
positioned higher up in the sample, meaning further away from the laser. 
However, cells can still be distinguished on the right side, proving the distribution 
of cells throughout the gel.  
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Figure 19.  Image of the channel in chip 3, 
treated with APTES and GA, from the top. 
Taken with confocal microscopy. Scale bar is 
200 µm.  
 
 
Figure 20. Image of the channel in chip 3 from 
the side. Taken with confocal microscopy. Scale 
bar is 200 µm. 
During the experiment most of the gels detached from the channel walls and the 
only chip in which the gel was still attached was the chip treated with APTES and 
GA. The reason for the high interaction between walls and gel when treated with 
APTES and GA is that the GA gets covalently bonded to the proteins in the 
hydrogel, creating a strong connection [89]. However, it is worth noting that the 
protocol for the APTES and GA treatment is more extensive than the other two 
protocols used in this experiment. Several sources have used PLL coatings and 
plasma oxidation for successful gel attachment to PDMS [5, 87, 90]. The degree 
of gel contraction typically depends on three different factors: collagen 
concentration, mechanical strength of the gel and cell density [91]. By varying 
one of these three parameters gel contraction can be decreased or completely 
avoided. An example of this is found in the article by Adriani et.al [9]. When 
using a pre-coating of poly-D-lysine and a low collagen concentration, gel 
contraction occurred. After increasing the collagen concentration of the gel, they 
did not have further problems with gel contraction [9]. Intentionally for this 
experiment, conditions were chosen so that high forces, due to a high cell 
concentration, would be exerted on a relatively weak matrix. This decision was 
made to ensure that the treatment chosen was sufficient to avoid gel contraction in 
later experiments, where the hydrogel concentration was to be varied.  
Due to the number of chips tested for each condition (between one and three 
chips), the reliability of the results are low. However, for this study it was chosen 
to rely on the results obtained from this experiment for further use.  
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4.3 Conclusion 
The aim of this experiment was to incorporate a hydrogel seeded with astrocytes 
in a microfluidic channel. To ensure high interaction between the PDMS-chip and 
the hydrogel, different surface treatments were evaluated. From the results 
obtained, the APTES and GA surface treatment proved strong connection. Due to 
these results the APTES and GA surface treatment was used for incorporation of 
hydrogels in microfluidic chips in later experiments.   
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5 Experiment 2: Hydrogel composition 
Astrocyte structure and function are dependent on the environment that they are 
cultured in. When cultured in 2D they adopt a stretched out morphology, atypical 
for in vivo astrocytes, and a high GFAP expression, which is a feature of reactive 
astrocytes. However, when cultured in 3D they show characteristic star-shaped 
morphology and a low GFAP expression, typical for their non-reactive state. 
Furthermore, it is assumed that the composition of the 3D culture environment 
may have an effect on cultured astrocytes. It has been reported that astrocytes tend 
to be less reactive when cultured in a collagen type I and HA hydrogel compared 
to when cultured in only collagen type I, and that also the ratio between collagen 
and HA concentrations will influence the reactivity. Therefore, an investigation 
on astrocyte morphology and reactivity when cultured at different collagen type I 
and HA concentrations was performed. The investigation will be carried out 
through image analysis where the intensity of GFAP expression was measured, 
shape of the cells was evaluated and number of processes was counted. 
Astrocytes seeded in different hydrogel composition were added to 12 
microfluidic chips. After 48 h the cells were stained in order to evaluate 
morphology and reactivity. Unfortunately, the viability of the cells was low. Since 
the amount of data obtained from the experiment was insufficient to draw any 
conclusions, it was decided to repeat the experiment with some changes to the 
method. It was hypothesized that the reason for the low viability was a 
combination of low cell concentration and high medium flow. Since astrocytes 
had already been cultured successfully in hydrogels in chips in previous 
experiments, the method was simplified in order to shorten time, by instead using 
a 96 wells plate for 24 h. Details about the method and results from the 
experiment carried out in chips can be found in appendix B. Hydrogel 
composition in chips, while in this section the experiment performed in a 96 wells 
plate are presented. 
5.1 Materials and methods 
In total, 18 wells to test nine conditions (2 wells/condition) were used for this 
experiment. In four of the conditions the collagen type I and HA concentrations 
were varied based on ratios found in literature [77, 92]. For positive controls 
culture conditions where astrocytes were more reactive were desired. Two 
conditions were used as positive controls for GFAP expression, astrocytes 
cultured in a collagen type I gel and on a 2D surface, and three conditions were 
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added as control for the antibody staining. In all hydrogels an astrocyte 
concentration of 1.0
.
10
6
 cells/ml was used at a passage number of 8 and astrocytes 
and endothelial cells cultured in 2D were seeded at a concentration of 3.0
.
10
4
 
cells/cm
2
. In the wells where endothelial cells (passage number 34) were to be 
cultured the surface was pre-coated with 40 µg/ml fibronectin for 1 h. In Table 2 
the different conditions and stainings used in the experiment can be found. As the 
stainings for actin and nucleus was applied to all conditions, they are not included 
in the table.  
Table 2. All conditions are summarized in the table. In the table the following information is 
provided; cell type (A – astrocyte and E – endothelial cells), collagen type I concentration, HA 
concentration, addition of primary antibody and secondary antibody. 
Condition 3D 
C 4 
3D 
C:HA 
3:1 
3D 
C:HA 
4:1 
3D 
C:HA 
5:1 
3D 
C:HA 
4:2 
3D 
C:HA 
3:1 
2D 
Astro 
2D 
Ab  
2D 
EC 
Ab 
Cell type A A A A A A A A E 
Collagen 
mg/ml 
4 3 4 5 4 3 - - - 
HA 
mg/ml 
- 1 1 1 2 1 - - - 
Primary 
Antibody 
+ + + + + - + - + 
Secondary 
Antibody 
+ + + + + + + + + 
 
All the gels were made according to the following protocol though with varying 
volumes depending on the condition (see appendix A. Hydrogels). 10X PBS, 1M 
NaOH and AM were added to Eppendorf tubes and put on ice. As preparation, 
HA was mixed with poly(ethylene glycol) diacrylate (PEGDA; Glycosan HyStem 
Trial Kit) at a ratio of 1:4 according to manufacturer’s recommendations. The 
appropriate volumes of collagen type I and HA were added to the tubes. In the 
final step the cells were detached from the culture flasks and resuspended in AM 
and added to the Eppendorf tubes. After mixing of the liquid gel through 
pipetting, 50 µl was added to each well. Endothelial cells and astrocytes cultured 
in 2D were added to the wells together with endothelial cell growth medium 
(EGM-2) or AM. The gels were left to incubate at 37
ᵒ
C for 30 min, to ensure 
proper gelation, before 50 µl AM was added to the wells.   
Medium was refreshed twice during the 24 h experiment by removing old 
medium through pipetting, and new medium was added in the same way. Time 
frames were taken at 4 h and 24 h with phase contrast microscopy. After 24 h the 
cells were fixated and stained with Texas red-X Phalloidin, NucBlue, primary 
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antibody rat anti-GFAP and secondary antibody goat anti-rat IgG Alexa Fluor 488 
(see appendix A. Staining of cells) and imaged with fluorescent microscopy. 
5.1.1 Image analysis 
To obtain a representative and concise set of images, a plane approximately in the 
middle of the height of the gel was chosen and fixed for all samples. All images 
were taken at 10 times magnification and the intensity levels for the three filter 
cubes used were fixed at 30% for the green fluorescent protein (GFP) filter cube, 
at 40% for the 4’,6-diamidino-2-phenylindole (DAPI) filter cube and at 40% for 
the red fluorescent protein (RFP) filter cube. There were two wells for each 
condition and from each well four frames were taken, making a total of eight 
frames for each condition. The position of each frame was chosen with the DAPI 
filter cube where the staining of the nucleus was shown and neither morphology 
nor GFAP-expression was distinguishable to prevent biased interpretation. In 
each position an image from each of the three filter cubes mentioned before was 
obtained. An example of such a set of images is seen in Figure 21A-C.  
 
 
 
 
 
 
Figure 21. In A-C an example of a frame taken with the three different filter cubes is shown; DAPI, 
GFP and RFP. In A the staining of nuclei is shown, in B the GFAP staining is visible and in C the 
actin staining. Scale bar is 200 µm. 
 
For image analysis the program ImageJ (1.48v, National Institutes of Health) was 
used. In the first step the number of cells present in the image was counted by 
hand. To do this, the image taken with the DAPI filter cube, showing the nuclei, 
was used. Firstly, the background noise was subtracted from the image using a 
rolling ball algorithm with the largest size radius set at 12 pixels. This value was 
optimized for the removing of background noise while maintaining information 
about cells close to the focal plane through testing of different radii sizes. 
Afterwards, a threshold for the intensity was set at 98% intensity for all images. 
Examples of a frame after the different steps had been carried out, together with 
the original frame, can be seen in Figure 22. From Figure 22C the number of cells 
was counted and only the cells visible in this frame were included during the rest 
A B C 
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of the analysis. If the nucleus of a cell was not seen in this image, it was not used 
for the analysis.  
 
 
  
Figure 22. In A-C three images are shown after subsequent steps performed during the image 
analysis. In A the original image taken with the DAPI filter cube shows the nuclei with a high 
background noise. In B the same image as A is shown after the background intensity has been 
subtracted. In C a threshold of the intensity has been set for the image shown in B. Scale bar is 200 
µm. 
 
In order to distinguish cells expressing GFAP and with a visible nucleus, an 
overlay of the two images was created. Afterwards, from the frames taken with 
the GFP filter cube, cells were divided into “in focus cells” and “out of focus 
cells”. This division was decided by the clarity of the cell body, where an 
example of a cell in focus can be seen in Figure 23A and a cell out of focus in 
Figure 23B. To analyze the GFAP expression for these cells it was needed to 
measure the fluorescence intensity and minimum intensity in the frame, which 
represented the background noise. In ImageJ the measurements were set to give 
the average intensity and minimum intensity per pixel. The cell shape was then 
drawn out with the use of the freehand drawing tool and the measurements were 
performed on this figure. Examples of the freehand drawing for a cell in focus and 
a cell out of focus can be seen in Figure 23C and D. For background noise the 
minimum intensity of the whole image was measured.  
For analysis of the morphology of the cells the frame taken of the GFAP staining 
was used and the visible cells were divided into two groups based on their 
morphology; star-shaped or elongated. The number of primary processes for cells 
defined as star-shaped was counted. Primary processes are processes that 
originate from the cell body, and in Figure 23A a primary process has been 
marked. 
To evaluate if the results of the average GFAP expression between conditions 
were statistically significant a Student’s t-test was performed. Comparisons were 
performed between all conditions for the total cells category. P values below 0.05 
were considered statistically significant. 
A B C 
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Figure 23. In A a cell defined as in focus is shown and a primary process is marked out while in B 
an example of an out of focus cell is shown. In C and D examples of freehand drawing on cells in 
and out of focus are shown. All images are taken with the GFP filter cube showing GFAP 
expression, and displayed in grey scale. Scale bar is 50 µm.   
 
5.2 Results and discussion 
The hydrogels and cells were added to the wells and cultured successfully for 24 
h. Although in two wells a bubble was incorporated in the gel, the effect on the 
gel was very low and no extra measures were taken. After 24 h the cells were 
fixated and stained. While the cells in the gels remained in place, during the 
staining some of the cells grown in 2D were washed away. Images from all wells 
were taken for analysis and examples of frames from each condition can be seen 
in Figure 24. 
A B 
C D 
Primary process 
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Figure 24. In A-F representative images from each condition used for analysis is shown as 
overlays of the three images taken with the three filter cubes; RFP, DAPI and GFP. Red is actin, 
blue is nucleus and green is GFAP. Consist for all images is that there is a high nuclei density 
where actin filaments are distinguishable, although the majority of these cells exhibit an elongated 
morphology. GFAP expression is distinguished for a low number of cells, however a larger amount 
of these cells have a star-shaped morphology Scale bar is 200 µm.  
 
  
A. 3D Coll 4 B. 3D Coll:HA 3:1 
C. 3D Coll:HA 4:1 D. 3D Coll:HA 5:1 
E. 3D Coll:HA 4:2 F. 2D Astro 
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What is seen in most frames is that there is a large number of cell nuclei visible 
together with a weak signal for actin. The signal for GFAP is strong in some cells, 
however from most cells there is no detectable signal. This large variation in 
signal levels for the actin and GFAP staining is especially visible by comparing 
the stainings in the same well with a lower magnification, which can be seen in 
Figure 25 and 26. From the GFAP staining a large number of star-shaped 
astrocytes are distinguishable from the background, while in the image showing 
the actin staining it is hard to distinguish cell structures from the background and 
from each other. This could be seen in all the wells, and due to the high 
background noise and difficulties to distinguish structures from the actin staining 
it was chosen not to use images taken with the RFP filter for the analysis.    
 
Figure 25. Image showing the GFAP staining in 
a gel. Imaged with GFP filter cube and the scale 
bar is 1000 µm.  
 
Figure 26. Image showing the actin staining in a 
gel. Imaged with RFP filter cube and the scale 
bar is 1000 µm. 
     
The analysis was performed to gain information about the reactivity of astrocytes 
in different gel compositions. Therefore, data about the average GFAP intensity 
per cell, number of GFAP positive astrocytes and the total amount of cells was 
obtained. In Graph 1 the percentage of total amount of cells expressing detectable 
levels of GFAP is shown. These results indicate a very low degree of GFAP-
positive astrocytes with a highest value of 6.9 % and lowest of 3.6 % of the total 
number of cells.   
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Graph 1. In the graph the ratio of GFAP positive cells against the total amount of cells is shown for 
the five gel conditions and the 2D condition. The blue bars show the total ratio of all the cells for a 
condition, while the green diamonds show the ratios for each of the two wells per condition. The 
highest percentage of GFAP positive cells was found in the 3 mg/ml collagen type I and 1 mg/ml 
HA gel and the lowest in the gel containing 4 mg/ml collagen type I 2 mg/ml HA. The ratios differ 
between 0.069 and 0.036.  
 
In Graph 2 the average GFAP expression per cell for each condition can be seen, 
where cells have been sorted in three categories: “in focus”, “out of focus” and 
“total cells”. From this graph it can be distinguished that the lowest average 
GFAP expression is in the only collagen type I gel. From the Student’s t-test the 
average GFAP expression of cells grown in 3D C 4 and 3D C:HA 3:1 were 
significantly lower than the other conditions (except between 3D C:HA 3:1 and 
3D C:HA 4:2 where no statistical difference was found), however between the 
two conditions there was no statistically significant difference.  
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Graph 2. In the graph the average intensity per cell is shown for the five different gel conditions 
and the 2D condition. The bars are divided into “in focus cells”, “out of focus cells” and “total 
cells”. Since all the cells were in focus in the 2D condition only a “total cells” bar is shown. 
Average intensity is obtained from the average pixel intensity for each cell normalized to the 
maximum pixel intensity. Both for average and maximum intensity the background intensity was 
subtracted. The standard deviation was determined from the average intensity with background 
noise subtracted, over all the cells for one condition. From the graph it is seen that the lowest GFAP 
expression for all three groups is found in cells grown in the 4 mg/ml collagen type I gel. Statistical 
significance was determined with a student’s t-test between the averages of total cells for all 
conditions. *P ≤ 0.05. 
The second parameter to be investigated is the morphology of the cells with 
respect to shape and number of primary processes. In Graph 3 the obtained results 
about the morphology of the cells has been summarized. In the graph it can be 
seen that a high percentage of the cells analyzed exhibits the star-shaped 
morphology, characteristic for astrocytes. However, more than half of the cells in 
all gels have fewer than 10 primary processes, which is a low number in 
comparison to other cultured astrocytes [77]. 
For the analysis of morphology the original idea was to analyze images showing 
the actin staining. Due to the high background noise it was decided to instead use 
the images taken of the GFAP staining, which decreases the amount of data as 
very few cells expressed detectable levels of GFAP (see Graph 1). Furthermore, 
to be able to analyze the morphology the cells needed to be close to the focal 
plane in order to distinguish its shape and the processes, decreasing the number of 
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suitable cells further. For these reasons the number of cells analyzed is too low to 
be statistically relevant. 
 
Graph 3. In this graph the morphology of GFAP positive cells have been summarized into four 
categories: cells with a star-shaped morphology and 1-5 processes (blue), cells with star-shaped 
morphology and 6-10 processes (red), cells with star-shaped morphology and 11-15 processes 
(green) and cells with an elongated shape (purple). For each condition the ratios of cells in each 
category has been divided with the total amount of cells used in the analysis for that condition. The 
total number of cells (N) for each condition are: NC4=9 cells, NC:HA3:1=19 cells, NC:HA4:1=9, 
NC:HA5:1=8 and NC:HA4:2=8.      
 
The results obtained from the analysis of GFAP expression indicate that the 
addition of HA to the hydrogel composition of cultured astrocytes does not 
necessarily decrease the reactivity of astrocytes. These results contradict the 
results found in another study, where a significant difference was presented [77]. 
Before a conclusion is drawn, the limitations of the used method and possible 
optimization steps are discussed.  
5.2.1 Method limitations and recommendations 
The method chosen for the experiment has a few steps that could be changed or 
optimized to increase the reliability of the results. In all of the images a lot of 
background noise is visible and especially from the actin staining it was 
problematic analyzing the images due to the high background noise. It is possible 
that the high amount of background noise blocks out information about less 
reactive astrocytes, causing limitations of the analysis. The cause for the high 
0 
0,1 
0,2 
0,3 
0,4 
0,5 
0,6 
0,7 
0,8 
0,9 
1 
3D C 4 3D C:HA 
3:1 
3D C:HA 
4:1 
3D C:HA 
5:1 
3D C:HA 
4:2 
R
at
io
 
Morphology of Astrocytes in 3D 
Elongated 
Star-shaped: 11-15 
processes 
Star-shaped: 6-10 
processes 
Star-shaped: 1-5 
processes 
0.56 
0.22 
0.22 
0.53 
0.16 
0.26 
0.05 
0.78 
0.11 
0.11 
0.50 
0.375 
0.25 
0.375 
0.125 
0.375 
53 
 
background noise can be due to the following suggestions: too thick gel layer, 
meaning that the cells in the other planes will have an impact on the image or due 
to over-staining; caused by too high dye dilutions, insufficient washing of the gels 
or non-specific binding of the staining. These are all problems that can be solved 
by optimizing the staining protocol and some suggestions of steps to improve are 
proposed in the following paragraph.  
In each well 50 µl of the gel was added causing a thickness of 1.5 mm, which will 
cause a lot of noise from planes out of focus in the plane being analyzed (compare 
it to the height of the microfluidic channel that is 375 µm). This is simply avoided 
by adjusting the thickness of the gel. Especially when a higher cell concentration 
is used a thinner gel is preferable. When it comes to over-staining it can usually 
be seen by the background noise. In our case we had a control for the antibody 
staining, where only the secondary antibody was added together with the staining 
for actin. The average intensity from these images is about 6% of the total 
intensity, which is relatively high. Although in this experiment the recommended 
dilutions (from manufacturer) were applied, it is always better to optimize the 
staining dilutions for the specific application, as the results can differ between 
systems. Especially for staining of cells inside a gel, optimization of the protocol 
is recommended as the incubation and washing steps need to be prolonged due to 
slower flow through the gel. Other recommendations to remove background noise 
are adding extra washing steps or prolonging the already existing ones as the 
washing occurs through diffusion which will take a longer time. Another idea 
could be to use another blocking buffer in order to prevent non-specific binding, 
and since in our system we are using a secondary antibody from goat, adding a 
goat serum could be a possible option for decreasing the non-specific staining. 
The background noise could be the reason for the low percentage of GFAP 
positive cells detectable, shown by Graph 1. However, this does not explain the 
reason for the low GFAP expression in the 2D control where there are very low 
levels of background noise, shown in Figure 24F. From the hypothesis a high 
GFAP expression should be distinguished from the astrocytes cultured in 2D, due 
to an increased reactivity. Furthermore, non-reactive astrocytes also express 
GFAP and therefore a higher percentage of cells expressing GFAP were expected. 
In literature it has been reported that there are several different types of astrocytes 
present in the brain and that not all of these express GFAP [93]. However, from 
manufacturer’s notes 95% of the astrocytes that were used for this experiment 
express GFAP (ScienCell). Another possible reason for the absence of GFAP 
could be loss of phenotype of the cell culture. In section 3.3.2 it is mentioned that 
the doubling capacity of the cells are limited. There is a possibility that a high 
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passage number (for this experiment passage 8 was used) of the cells may have 
altered their phenotype, causing the absence of GFAP expression. It is always 
recommended to use a low passage number, especially when working with 
primary cells.   
All images were analyzed using ImageJ and during the analysis certain choices 
were made. In the method chosen a lot of the analysis was done manually, such as 
counting the cells and drawing out the cell shape for intensity measurements. By 
performing the analysis manually human errors can be included as well as 
differences between the analysis of different cells. An option is to create an image 
analysis program to standardize the method and ensure fewer differences in 
analysis between cells. A problem with an image analysis program is that the 
images used are taken in a gel, causing cells in other planes to influence the 
analysis. Such a program needs to be capable of distinguishing between cells in 
plane and out of plane. In a try to manually remove cells out of plane from the 
analysis, a threshold was set for the intensity of the nucleus and only cells with a 
visible nucleus were analyzed. This meant that even if a cell was clearly visible 
with actin and GFAP staining it would not be used for analysis if the cell nucleus 
was not visible. A clear example of this situation is shown in Figure 27, where a 
visible cell without a corresponding nucleus is shown, meaning that for this 
analysis it was not included.  
One of the main goals with the image analysis was to choose a method that is as 
objective as possible in order to not be biased by our expectations, which 
unfortunately complicated the image analysis. When imaging in gels the cells will 
be spread out throughout the planes making it problematic to visualize the 
complete morphology of the cells. The cells will also be spread out in the 
different planes, limiting the amount of cells to analyze if the plane is fixed, like 
in the method chosen in this experiment. To ensure a higher cell density in the 
planes the cell concentration could be increased, although then there will be more 
background noise as well that may affect the results.   
One solution to the problems obtained with the current method is imaging with a 
confocal microscope instead of a fluorescent microscope. With a confocal 
microscope 3D images are obtained by imaging the different planes and 
reconstructing the 3D volume. This has the advantage of removing the 
background noise caused by cells in other planes, but also the possibility to see 
the complete morphology of the cells, as the processes are spread out through 
different planes. A dilemma with using a confocal microscope is that the focus 
depth is limited and in order to receive high quality images there are limitations 
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on the thickness of the culture device. An alternative way of analyzing GFAP 
expression is through Western blot, a technique used to detect and measure 
proteins, which has been used in literature to evaluate GFAP expression levels in 
astrocytes [94-95]. Even though the information about the expression on a single 
cell level will be lost, more precise results of the total GFAP expression will be 
obtained.      
 
Figure 27. One of the frames where a clearly visible cell body (inside the yellow rectangle) is seen 
through expression of GFAP, although there is no visible cell nucleus corresponding to the cell 
body. Therefore, the cell was not used for analysis. Image taken with GFP and DAPI filter cubes.  
 
5.3 Conclusion 
In this experiment the influence of culture environment on astrocyte reactivity and 
morphology was evaluated. Astrocytes were cultured in different combinations of 
collagen type I and HA hydrogels and compared to conditions reported to induce 
a higher reactivity, such as a collagen type I gel and a 2D surface. In the results 
obtained from the image analysis of GFAP expression less than 10% of cells in all 
conditions expressed detectable levels of GFAP and the on average lowest GFAP 
expression were found in the 4 mg/ml collagen type I and the 3 mg/ml collagen 
type I and 1 mg/ml HA hydrogels. From the morphology data a majority of cells 
analyzed exhibit a star-shaped morphology, although the amount of cells used for 
the analysis were too few to make it statistically relevant.  
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Due to the limitations of the used method the choice of gel combination used for 
the following experiment will also be influenced by the results from the article by 
Placone et.al [77]. Therefore, the gel concentration of 3 mg/ml collagen type I and 
1 mg/ml HA was chosen for further use.  
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6  Experiment 3: Co-culture in a BBB-chip 
The main component of the BBB is a monolayer of endothelial cells that makes 
up the physical barrier between brain and circulatory system, making it the main 
target for BBB modeling. However, astrocytes that are in close contact with the 
barrier through their endfeet are hypothesized to play a role in inducing and 
regulating BBB-specific properties of the brain endothelial cells. To evaluate the 
influence of astrocytes on endothelial cells a co-culture system inside a 
microfluidic chip was established where the barrier tightness was assessed 
through TEER measurements. It was expected to see a slight increase in TEER 
between chips containing a co-culture of endothelial cells and astrocytes 
compared to chips seeded with only endothelial cells.  
6.1 Materials and methods 
In the experiment a total of 15 chips for four conditions were tested. The different 
conditions and number of chips for each condition is shown in Table 3. The 
design of the PDMS chip (described in section 3.1) used for all conditions 
contains a top and bottom channel aligned perpendicular to each other, creating a 
crossing of the channels in the middle of the chip with a polycarbonate membrane 
separating the channels (for protocol see appendix A. Chip fabrication).  
Table 3. Summary of the four different conditions used in the experiment. For condition 1 six chips 
were used where endothelial cells and astrocytes in a hydrogel were present. In condition 2 three 
chips were used with astrocytes in a hydrogel present, while endothelial cells were absent. In 
condition 3 three chips were used with endothelial and a hydrogel, however there were no astrocytes 
incorporated in the gel. In condition 4 three chips were filled with endothelial cells while the 
hydrogel and astrocytes were absent. 
Condition 1 2 3 4 
Endothelial 
cells 
+ - + + 
Astrocytes + + - - 
Hydrogel + + + - 
Chip 
number 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
 
After chip assembly the channel surfaces were functionalized with APTES and 
GA according to the protocol described in section 4.1. The chips were kept in the 
oven at 60
ᵒ
C for 2 h and afterwards coated with a 10 µg/ml solution of collagen 
type I and incubated at 37
ᵒ
C for 30 min. The pre-coating of collagen was added to 
ensure the stability of the surface treatment over a longer storing time. The 
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collagen solution was aspirated from the channels and the chips were stored at 
60
ᵒ
C over night. 
Electrodes were cut into pieces from a platinum wire with a diameter of 200 μm 
(Alfa Aesar). After aligning the electrodes in the middle of the channels, UV-
curable glue was added to the opening of the electrode channel (Norland Optical 
Adhesive 81, NOA81). Through capillary forces the glue entered the channel and 
when cured with ultraviolet (UV) light (350 mW/cm
2
 for 5 s), it fixated the 
electrode in the channel. Chip and electrodes were attached to the bottom of a 
plastic dish with a 2-component epoxy adhesive (Loctite M-31 CL Hysol, 
Henkel) and baked in the oven at 40
ᵒ
C over the weekend. An image of a fully 
assembled chip can be seen in Figure 28.   
 
Figure 28. Image of the assembled two-compartment chip containing two channels 
aligned perpendicular to each other. The two channels are separated by a membrane and 
in each channel two electrodes are introduced on each side of the membrane. The chip is 
glued to a plastic dish.   
 
The chips were kept at 4
ᵒ
C for 2 h prior to adding cells. 10X PBS, 1M NaOH and 
astrocyte medium were added to Eppendorf tubes and kept cold. Astrocytes 
(passage 4) were detached from their flasks and cell concentration was counted. 
Collagen type I (3 mg/ml) was added to the cold Eppendorf tubes, HA (1 mg/ml) 
and PEGDA were mixed together (through pipetting) in a separate tube and 
directly afterwards pipetted into the Eppendorfs. Lastly, the cells suspended in 
AM were added to the gel (1.0
.
10
6
 cells/ml) and directly after thorough mixing 
through pipetting, the liquid gel was added to the bottom channels (see appendix 
59 
 
A. Hydrogels). The chips were incubated at 37
ᵒ
C for 30 min to make sure the 
hydrogel had gelled prior to adding AM and directly afterwards the top channel 
was coated with fibronectin at a concentration of 40 µg/ml. Chips were incubated 
for 1 h and afterwards flushed with EGM-2. 
TEER measurements of the blank chips were performed prior to seeding the 
endothelial cells in the chips (see section 2.2.3 about TEER measurements). In 
order to seed the endothelial cells (passage 34) in the chips they were detached 
from the flasks and pipetted into the top channel at a concentration of 5.0
.
10
6
 
cells/ml. The chips were kept in the incubator for 1.5 h before flushing the 
channel with EGM-2. Every morning and afternoon medium for the bottom 
channel (AM) and top channel (EGM-2) was changed and approximately 2 h after 
the medium was changed in the morning, TEER measurements were carried out. 
On the fifth and last day of the experiment the cells were fixated and stored in 1X 
PBS at 4
ᵒ
C over the weekend. The staining protocol described in appendix A. 
Staining of cells was performed using NucBlue and ActinGreen.   
6.2 Results and discussion 
TEER series for the 15 chips showing the membrane resistance values for the five 
days duration of the experiment are shown in Graph 4-7, in which the results have 
been summarized depending on condition. To obtain the TEER value the 
resistance obtained on day 0 needs to be subtracted from the values of the 
following days.  
In Graph 4 the TEER values from the co-culture systems are summarized. In a 
typical TEER measurement a low resistance is measured on the blank chip (day 0) 
and after the addition of endothelial cells an increase in resistance is expected. 
This increase is due to the formation of the cell monolayer and the tight junctions 
between the cells, which commonly takes a couple of days. Only in chip 1 a 
typical TEER series is measured, while in the other chips the resistance either 
stays more or less constant (chip 3-5) or is even decreased (chip 1). In chip 2 a 
negative resistance is measured on day 0, however on the other days of the 
experiment a positive value is measured.  
In Graph 5 the TEER series of condition 2 has been summarized. In these chips 
no endothelial cells were added and therefore it is not expected to see an increase 
in TEER values. In one chip the resistance stays constant throughout the 
experiment, while in the other two chips differences in resistance can be seen for 
the two first days, and afterwards they as well become constant. Worth noting is 
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that on day 0, when a blank measurement was carried out, a very high resistance 
was measured in chip 9.  
In condition 3 and 4 endothelial cells were added in the top channel while in 
condition 3 only the hydrogel was added and in condition 4 the bottom channel 
was only filled with medium. In both Graph 6 and 7 either a decrease or increase 
in resistance can be seen in most of the chips between day 0 and 1, and for the 
remaining days only small variations in resistance are measured.  
From the TEER series only in one of the chips a characteristic TEER 
measurement is seen. In most of the other chips a constant TEER at a low value is 
shown from day 1 or 2, indicating that there is no monolayer of endothelial cells. 
The large variation in TEER values typically seen between the first days can be 
due to disturbances or changes in the system. From images taken at the same time 
as the TEER measurements, on day 0 large bubbles either directly in contact with 
the electrodes or blocking the channel are seen (Figure 29 and 30). These bubbles 
may be the cause for the atypical resistance values seen the first days. In three of 
the chips (chip 2, 10 and 13) a negative resistance is obtained on the first day of 
measurements. This is most likely due to bubbles either blocking or covering both 
electrodes in a channel, causing a high resistance across the channel. From 
equation 10 (see section 3.4.2) it can be understood how a high resistance along 
one or both of the channels can cause the calculations of the membrane resistance 
to become negative. However, after one or two days the bubbles had typically 
disappeared, which may be the explanation for the large variations between the 
days. Other factors that may influence the TEER measurement is if there is any 
damage to the membrane or the pores are partly blocked, which can typically be 
distinguished by higher resistance values that causes a constant offset in the 
measurements.       
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Graph 4. A graph showing the TEER series at 
10 kHz for chip 1-6. In the graph the membrane 
resistance (Ω*cm2) over time (days) is shown 
for the chips.. In chip 3,4 and 5 a nearly constant 
membrane resistance for all measurements were 
obtained. In chip 1 the membrane resistance 
decreased with time until the last two days when 
it was constant. In chip 2 the membrane 
resistance is negative on day 0 and on day 1 it 
has increased to above 0 Ω*cm2, however for 
the days to follow the value is constant. In chip 
3 an increase can be seen in membrane 
resistance from day 0 to day 2, and in the 
following days a small decrease is measured. 
 
Graph 5. A graph showing the TEER series at 
10 kHz for chip 7-9. In the graph the membrane 
resistance (Ω*cm2) over time (days) is shown 
for the chips. In chip 7 a low membrane 
resistance was constant over the five days. In 
chip 8 the resistance decreased from day 0 to 
day 1, however on day 2 it went back to the 
same resistance as day 0 and stayed constant for 
the rest of the experiment. In chip 9 a large 
resistance was measured on day 0 which by day 
1 had decreased to close to 0 Ω*cm2. At day 2 
the resistance had increased to approximately 5 
Ω*cm2, and stayed constant at this value for the 
days to follow. 
 
Graph 6. A graph showing the TEER series at 
10 kHz for chip 10-12. In the graph the 
membrane resistance (Ω*cm2) over time (days) 
is shown for the chips. In chip 10 and 12 the 
resistance stayed close to 0 Ω*cm2 for the full 
duration of the experiment. In chip 11 a high 
resistance of 60 Ω*cm2 was measured on day 0 
and on day 1 it was decreased to half that value, 
where it also stayed constant until the last day. 
 
Graph 7. A graph showing the TEER series at 
10 kHz for chip 13-15. In the graph the 
membrane resistance (Ω*cm2) over time (days) 
is shown for the chips. In chip 13 the membrane 
resistance started at a negative value on day 0. 
For day 1-4 the resistance was constant at 
approximately 5 Ω*cm2. In chip 14 a high 
resistance was measured on day 0, and for the 
remaining days it kept on decreasing. In chip 15 
a high membrane resistance was first measured 
and after a decrease between day 0 and 1 the 
value stayed more or less constant.  
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Figure 29. Image of a bottom channel where a 
large bubble has been incorporated in the gel. 
Taken with phase contrast microscopy with a 
scale bar of 1000 µm. 
 
Figure 30. Image of a top channel where a 
bubble has been incorporated in the fluid-filled 
channel. Taken with phase contrast microscopy 
with a scale bar of 1000 µm. 
 
6.2.1 Top channel 
The TEER series obtained indicated that no monolayer of endothelial cells had 
been formed. From images taken with the phase contrast microscope it is shown 
that viable endothelial cells were present in the channels on day 1 after seeding. 
After this day a decrease in viability is observable each day, and by the end of the 
experiment the layer of endothelial cells in the chips was discontinuous and most 
cells had a rounded morphology, indicating that the cells were dead. The 
decreased viability can be seen by comparing images taken of a chip at day 1 and 
day 4 (Figure 31 and 32).  
 
Figure 31. Image of the top channel in chip 2 on 
day 2 where endothelial cells are visible. Taken 
with phase contrast microscopy with a scale bar 
of 200 µm. 
 
Figure 32. Image of the same top channel as 
seen in Figure 31 on day 4 with few cells 
visible. Taken with phase contrast microscopy 
with a scale bar of 200 µm. 
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The same behavior was observed in all chips except for one, where endothelial 
cells grown on the membrane created a monolayer. For chip 6 a characteristic 
TEER measurement was obtained and the monolayer is visible with fluorescent 
staining for nucleus and actin (see Figure 33). Worth noting is that in this chip it 
can be seen that on the surface of the channel next to the membrane very few 
viable cells are present. 
 
Figure 33. Image of the top channel showing a part of the channel and the membrane in chip 6. A 
monolayer of endothelial cells is seen grown on the membrane. Yellow dots mark the beginning of 
the membrane (moving from left to right). Stained with ActinGreen and NucBlue and images taken 
with fluorescent microscope using GFP and DAPI filter cubes. Scale bar is 200 µm. 
 
The protocol used for chip fabrication, seeding of endothelial cells and TEER 
measurements is a standardized protocol used several other times without 
complications [61]. Therefore it would seem most likely that the reason for the 
low viability is due to one of the newly added protocols or one of the materials 
used. In the discussion to follow some of the possible causes are brought up and 
discussed. 
One source of variation between experiments is the cells. A different passage 
number can have an effect on the cell function. Other factors which may influence 
the viability of the cells are infections, such as mycoplasma, and air bubbles in the 
channels. For this experiment the endothelial cells were passaged into three flasks 
the weekend before the experiment, where two flasks were used for this 
experiment and one flask for another experiment, independent of the one 
presented here. The cells in the other experiment did not show any abnormal 
behavior and a high viability. This indicates that the problem may instead be due 
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to the interaction between cells and device. The main material that the cells are in 
contact with is the PDMS and one of the reasons for using PDMS in BioMEMS is 
its biocompatibility. However, uncured PDMS is capable of diffusing through the 
chip and enter the culture channel, which may influence the cells. The curing 
process of PDMS is temperature and time dependent and despite a proper curing 
protocol it is hard to ensure the absence of uncured PDMS [96]. The chips used 
for this experiment were stored either for one or two weeks prior to use at room 
temperature and at 40
ᵒ
C for 72 h before adding cells to the chips. Due to the long 
storing times and exposure to high temperatures, only a low amount of uncured 
PDMS should be present, although this has not been proven. Other materials of 
the chip that were in contact with the cells are the electrode parts, consisting of 
platinum electrodes and UV-curable glue. Platinum is a metal with high 
biocompatibility and has been used in several biomedical applications [97]. The 
glue is a polymer that cross-links when exposed to UV and has been reported to 
have a high biocompatibility [98]. However, for the chips used in this experiment 
the glue looked damaged after having been stored in the oven over the weekend. 
This appearance had been seen in a previous smaller scale experiment, where the 
same chip design treated with APTES and GA was stored in a desiccator over the 
weekend. Comparison of a channel containing the glue in its normal state and the 
damaged glue is shown in Figure 34 and 35. 
 
Figure 34. Image of an electrode channel 
containing an electrode and UV-curable glue. 
The typical appearance of the glue is shown 
Chip without surface treatment stored in room 
temperature. Taken with phase contrast 
microscopy and scale bar is 1000 µm. 
 
Figure 35. Image of an electrode channel 
containing an electrode and UV-curable glue. 
The atypical appearance of the glue is shown. 
Chip with surface treatment and stored in an 
oven. Taken with phase contrast microscopy and 
scale bar is 1000 µm. 
 
The reason for why the glue had changed in appearance has not been determined; 
however, a couple of possible reasons will be mentioned. The glue used for this 
experiment, as well as for the smaller experiment mentioned above, was past its 
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expiration date and there is a risk that the exposure time used was not enough to 
cure the glue completely. Another possibility could be that the interaction 
between the surface functionalization and the glue has an influence on the curing 
of the glue. This appearance of the glue, seen in Figure 35, has only been seen 
after the two protocols were combined. As the surface treatment is carried out 
before the electrodes are added it may have an effect on the curing of the polymer.    
Another step added to the standard culture protocol for endothelium on chips is 
the surface functionalization with APTES and GA. As growing cells directly on 
the treated surface would cause harm to the cells, the APTES and GA treated 
surface was coated with collagen type I and fibronectin prior to seeding, which 
should be enough to create a biocompatible surface for the cells to attach to 
according to literature [70]. 
Without further experiments it is not possible to determine the exact reason for 
the decreased viability of the endothelial cells.  
6.2.2 Bottom channel 
Apart from the endothelial cells in the top channel, astrocytes were seeded in a 
hydrogel in the bottom channel. In most chips the gels had detached partly or 
completely from the walls by the end of the experiment. The cell density was low 
and in some gels the cells showed a rounded morphology, indicating a decreased 
viability of the astrocytes inside the gel. In case of gel detachment the largest 
detachment was in general close to the inlet where the medium was refreshed. 
Inside the gels few viable astrocytes with the characteristic star-shaped 
morphology could be found and instead most cells had an elongated morphology.  
In the first experiment different surface treatments to avoid gel detachment from 
the walls were evaluated, and the treatment with APTES and GA was chosen due 
to its high interaction with the hydrogel. However, in this experiment most of the 
gels had detached by the last day of the experiment, despite surface 
functionalization. Although the cause for this is not certain, there are three things 
worth mentioning that may have had an influence. Firstly, the largest degree of 
detachment was in almost all cases close to the inlet where the medium was 
refreshed. Medium refreshing was carried out by first adding a pipette tip of 150 
µl to the inlet and afterwards a pipette tip with 100 µl to the outlet. Especially 
when the first pipette tip is inserted it will cause high forces on the gel which 
could cause the detachment in the case of an already instable gel. Secondly, in the 
gels where no astrocytes were present gel detachment could also be seen, however 
it tended to be smaller than in the gels containing astrocytes. This indicates that 
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forces exerted by cells on the gel matrix contribute to the detachment. Therefore, 
a more stable gel, for example through higher gel concentration, could be a 
solution for decreased detachment. Thirdly, at day 0, in almost all the chips with 
gels, bubbles were incorporated in the gels in proximity to the electrodes (see 
Figure 36 and 37). The incorporation of air bubbles in the gel can either have 
occurred during the mixing of all gel components through pipetting, or after 
adding the gel to the chip. The gels were made in four different tubes and all of 
them were carefully mixed in order to ensure that no bubbles would be 
incorporated. The fact that bubbles are seen in all chips makes it unlikely that the 
bubbles were created during the mixing. Also, in other experiments using the 
same method for mixing but chips without electrodes, there were rarely any 
problems with bubbles. For this reason it is thought that either the electrode 
integration or the electrode in itself is the cause for the air bubbles. The UV-
curable glue used to attach the electrodes to the channels cross-links when 
exposed to UV. This cross-linking will cause it to shrink, causing a gap between 
the channel wall and the glue. This was visualized in a video where the curing 
procedure was filmed, where it is possible to see the glue detaching from the wall 
of the channel when being cured. This could be a possible source of the air 
bubbles. Another possibility is the application of a potential during the TEER 
measurement, causing electrolysis of water. Electrolysis is the process of splitting 
water molecules into hydrogen and oxygen gas by applying an electrical potential. 
As in theory a potential of 1.2 V is needed for electrolysis while in the TEER 
measurements a potential of 0.3 V is applied to the electrodes, it is not likely that 
this is the source of the bubbles in this system [99]. After one or two days the 
bubbles break, causing the gel to be detached from the wall in those spots. When 
medium-filled pipette tips are added the detached part will be the preferred path 
for the medium to flow, causing higher forces on the gel that is still attached to 
the wall, accelerating the detachment process.  
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Figure 36. Image of chip 5 close to the 
electrode in the bottom channel. Several bubbles 
are incorporated in the gel, close to the 
electrode. 
 
Figure 37. Image of chip 3 close to the 
electrode in the bottom channel. Two bubbles 
are incorporated in the gel, close to the 
electrode. 
       
Apart for the complications with gel detachment the viability of the astrocytes in 
the gel varies between chips. In some chips a good viability is seen (Figure 38), 
while in other chips there are no visible cells at all. This could be related to 
problem of the decreased number of endothelial cells, although their different 
culture protocols inside the chip will make some of the alternatives given in the 
discussion about the viability of the endothelial cells less likely. The astrocytes 
are cultured inside a gel, causing them to not be in contact with surfaces of the 
channel. In parts of the channels where the gel has detached the astrocytes are 
growing on the channel with a high viability (see Figure 39). This could be 
because parts of the gel are covering the surface, allowing the astrocytes to grow 
on it without being in any contact with the surface functionalization. Another 
possibility brought up in the previous discussion was the electrode integration. 
Since electrodes are inserted in the bottom channel, this could be a possible cause 
for the decreased astrocyte viability. However, once again it needs to be 
mentioned that the cause cannot be determined without further investigation. 
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Figure 38. Image of the bottom channel 
showing astrocytes spread out in a gel. Taken 
with fluorescent microscope using DAPI and 
GFP filter cubes. Scale bar is 200 µm. 
 
Figure 39. Image of the bottom channel where 
the hydrogel has been detached. Astrocytes 
grown on the bottom of the channel can be seen 
(all in focus). Taken with fluorescent 
microscope using DAPI and GFP filter cubes. 
Scale bar is 200 µm. 
 
6.3 Conclusion 
In the third experiment endothelial cells and astrocytes seeded in a hydrogel 
where co-cultured inside a BBB-chip to evaluate the influence of astrocytes on 
the barrier. From the results obtained it is hard to draw any conclusions about the 
effects of astrocytes on barrier tightness as there were no continuous monolayers 
of endothelial cells. However, there are several examples of similar co-culture 
systems in literature and a discussion about co-culturing systems can be read in 
section 7.3. Instead, what can be concluded from this experiment is that the 
current chip design may not be optimal for the incorporation of a hydrogel to 
establish a co-culture system.   
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7 Discussion 
In this section three topics will be discussed in further detail. First of all, the chip 
design and its suitability for hydrogel incorporation will be discussed. In the 
second section a summary of the importance of the culturing environment on 
astrocytes will be given, that is based both on literature and results from the 
experiment. In the third and final section the effects of co-culturing endothelial 
cells and astrocytes based on literature will be discussed. 
7.1 Chip design 
In the final experiment the goal was to co-culture endothelial cells and astrocytes 
seeded in a hydrogel inside the BBB-chip that was previously developed.  
The BBB-chip had been optimized for growing a monolayer of endothelial cells 
exposed to shear stresses and measuring the TEER across the barrier. With the 
bottom channel previously being used for medium, the potential of incorporating 
astrocytes within this channel was promising. This would allow for the two cell 
types to be cultured in proximity to each other, only separated by a membrane. To 
culture astrocytes in the bottom channel they could either be grown directly on the 
surface of the channel or inside a hydrogel. Since astrocytes cultured in 2D are 
reported to have a less physiologically relevant behavior compared to cells 
cultured in 3D, it was decided to incorporate the cells in a hydrogel [100].  
Due to the hydrophobic nature of PDMS, interactions between hydrogel and 
channel walls are low which may cause the hydrogel to detach from the channel. 
With the addition of cells exerting forces on the hydrogel structure the risk 
increases. Therefore a strong interaction between the hydrogel and channel walls 
was desired and by functionalizing the PDMS surface with APTES and GA this 
strong interaction was achieved. However, the protocol for the surface treatment 
is more extensive than other commonly used treatments for increased PDMS 
functionalization and it was also discussed earlier in this report about the 
compatibility between the surface treatment and the UV-curable glue (see section 
6.2.1). There are some options to be considered with the current protocols. To 
achieve strong enough interactions without using the APTES and GA treatment 
the gel composition or cross-linking can be increased and also another chip 
material that is more hydrophilic could be considered. Another option is to change 
the chip design in order to decrease the forces applied to the gel structure, making 
it more suitable for the incorporation of a hydrogel.    
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Fluidic flow through a gel is a tedious process and depends on the composition of 
the gel. By adding the fluid with a higher pressure the flow rate can be increased. 
This will also mean that the gel will be exposed to higher forces, creating a 
greater risk for gel detachment. Another argument against increased flow rate is 
its influence on the cells. The second experiment presented in this report was first 
carried out in microfluidic chips, where the flow rate of the medium had been 
increased from experiment one to two. By the end of the experiment few viable 
cells with processes were visible, and it was hypothesized that the cause was the 
high medium flow in combination with the low cell concentration, due to the 
forces exerted on the cells in combination with low signaling between cells (both 
due to the flow and low cell concentration). From literature examples of different 
chip designs for hydrogel incorporation in a microfluidic chip can be found. One 
example is to have separate hydrogel and medium channels, where the medium 
will reach the cells inside the hydrogel through diffusion [9]. In another device a 
hydrogel chamber containing an array of micro-pillars is connected to two 
microfluidic channels. The micro-pillars are used as a physical support for the 
hydrogels, allowing the use of lower gel concentrations and softer gels [101]. 
Even though it is not the optimal design for the incorporation of a hydrogel, gel 
attachment was achieved in both experiment one and two after surface 
functionalization with APTES and GA.  
In the third experiment though, unforeseen problems with gel detachment 
occurred.  
In the first two experiments a single-channel PDMS chip connected to a PDMS-
coated glass cover slip was used. For most of these chips treated with APTES and 
GA the interactions between channel walls and hydrogel were strong which led to 
high attachment. In the third experiment, however, in the edges of the channels 
electrodes had been integrated by fixating platinum electrodes into a separate 
channel with glue that cross-links when exposed to UV. In these chips air bubbles 
were seen in almost all the gels and the gel had detached close to the inlet, outlet 
and the electrodes in several chips. The detachment of the gel is most likely due 
to the bubbles, that after breaking will cause detachment of the gel from the wall, 
or that the channels are not properly filled with the gel due to the electrodes. The 
cause for the formation of the bubbles is not yet determined, although there are a 
few possibilities that have been considered. When the UV-curable glue is cross-
linked, it detaches from the channel wall leaving a small gap that will be air-filled 
prior to adding the gel. Although it is still not certain whether this is the source of 
the air bubbles, the electrode compartment seems to be the most likely cause for 
the problems in incorporating hydrogels in the bottom channel of the chip. Further 
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investigations into what is causing the air bubbles is needed before a co-culture 
system can be established.  
The co-culture system in the current design is established by culturing the cells in 
two channels separated by a polycarbonate membrane with a pore size of 4 µm 
and a thickness of 10 µm. The membrane is added for structural support of the 
endothelial cells that are in need of a surface to adhere to. In the co-culturing 
system this membrane will create a distance between the two cell types, causing 
low interaction between them. Direct contact between the two cell types would 
more resemble the in vivo situation, although for the current chip design the 
feasibility of such a direct co-culture system is low. However, such a system does 
not only depend on the chip design, but also on the structure of the hydrogel. 
Endothelial cells exert high forces on the surface that they are grown on, and to 
avoid gel contraction the gel needs to be strong enough or have enough support to 
withstand those forces.  
7.2 Culturing condition’s impact on astrocytes 
The effect of the environment on cultured astrocytes has not been given a lot of 
attention. There are some reports on the effect of culturing astrocytes in 2D 
compared to 3D when it comes to reactivity [100], but the effect of culturing the 
cell type in different gels is not very extensively investigated.  
The most commonly used hydrogel for culturing astrocytes is a collagen type I 
gel. However, collagen type I is only present at very low levels in the healthy 
ECM of the brain and especially for primary cells this may have an effect on their 
molecular expression as well as their functions. In the article by Payne and Huang 
[102] it is claimed that when there is cancerous tissue in the brain, elevated levels 
of collagen type I can be found in the brain. In that case the presence of collagen 
type I is a sign of injury to the brain, which in theory should lead to an increased 
reactivity of the astrocytes. In other studies such it has been shown that the 
addition of HA, which is one of the most abundant components of the ECM in the 
healthy brain, can decrease the glial scar formation that is connected with 
astrocyte reactivity [103]. Therefore the addition of HA would make the hydrogel 
resemble the natural ECM more and cause a lower reactivity of the cells, as seen 
in the article by Placone et.al. [77].  
In the results obtained from the experiment presented in this report a higher 
GFAP expression could be seen in the conditions with a higher polymer 
concentration. However, no statistically significant difference could be seen for 
the GFAP expression between cells cultured in the 4 mg/ml collagen type I and 3 
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mg/ml collagen type I and 1 mg/ml HA hydrogels. In the article by Partyka et.al 
[92] they compared astrocytes grown in a collagen type I and a mixture of 
collagen type I, HA and Matrigel hydrogel. In the images presented in the paper 
there is a very low degree of GFAP expression in both the collagen and the 
collagen and HA gel and there is no visible differences in expression levels 
between the gels. It is not until the addition of EGM to the astrocytes that an 
increased GFAP expression is visible. However, they do not present a comparison 
of reactivity and morphology of astrocytes between the two gels. The results 
indicate that the addition of HA to the hydrogel is not the factor that influences 
the reactivity of the cells the most. The trend that can be seen in this study, which 
has also been reported in the article by Placone et al [77], is that the mechanical 
properties, such as stiffness and relaxation rate, of the gel will also have an 
influence on the reactivity. A higher total polymer concentration will cause a 
stiffer gel, and there are indications that the stiffness of the gel may be an 
important factor for astrocyte reactivity and morphology, as well as the relaxation 
rate. Complementary tests of the mechanical properties of the gels used to culture 
astrocytes could provide interesting and useful information in future studies.  
In this study the ratio GFAP positive cells was also very low. One likely reason 
for the low degree of cells visibly expressing GFAP is that there is a very low 
degree of expression in the cells and that the background noise is too high for 
these lower levels of expression to be detected. However, from the 2D condition, 
where a very low background noise was measured, a low ratio of GFAP 
expressing cells was detected, possibly due to loss of phenotype. Further 
investigation is needed to decide the cause for the few GFAP positive cells. 
However, since the amount of data obtained from this study, both on GFAP 
expression and morphology, is not enough to be statistically relevant, no 
conclusion can be drawn about the effect of culturing environment on astrocytes.      
7.3 Co-cultures  
While a monolayer of endothelial cells is the component that builds up the barrier 
between brain and circulatory system, the barrier is strongly influenced by its 
surrounding environment. When modeling the BBB with only endothelial cells a 
lot of information is lost, and therefore co-cultures with other components of the 
NVU is becoming more commonly used. Astrocytes are one of the cell types that 
have been given a great deal of attention and interest due to their capability to 
induce BBB-specific properties of the endothelial cells, and there are several 
studies on co-cultures of endothelial cells and astrocytes. However, the extent of 
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astrocyte influence on barrier properties differs between studies, and also between 
cell lines.  
For the experiments presented in this report the immortalized cell line 
hCMEC/D3 was used. Since the cell line is obtained from human brains, 
signaling pathways, protein expression and metabolism are the same. The main 
problem with this cell line is the low barrier tightness, causing a higher 
permeability of smaller molecules across the barrier. Due to its other promising 
qualities for BBB research, possibilities to increase the tightness of this cell line 
have been investigated. Two methods that have been especially looked into are 
the application of shear stress to the cells by applying a flow, and co-culturing the 
cell line with other cells known to induce BBB properties, such as astrocytes and 
pericytes. In static models where hCMEC/D3 are co-cultured with astrocytes a 
small increase in TEER values can be observed, while when co-cultured with 
pericytes no significant increase is shown. What seems to have a larger influence 
on the hCMEC/D3 cell line is the addition of shear stresses to the cells, at least 
when looking at TEER values [49, 104]. 
Therefore, the question arises about the need for co-culture systems when 
working with the hCMEC/D3 cell line, if there is only a small increase in barrier 
tightness. One thing to keep in mind is that astrocytes not only induce BBB 
properties, but may also be involved in the disruption of the BBB during damage 
to the brain [105]. The reactive state of astrocytes leads to functional and 
molecular changes of the cells, which may influence the BBB. In a study by 
Hawkins et.al [12] co-culturing endothelial cells and astrocytes in a Transwell 
system did not result in a statistically significant increase of the TEER value 
compared to culturing only endothelial cells, both when astrocytes were cultured 
in 2D and 3D. However, when adding an agent that causes increased reactivity of 
astrocytes, a decreased TEER was measured compared to when the agent was 
added to the system containing only endothelial cells.  
Although the importance of astrocyte reactivity on the BBB has not been given a 
lot of attention yet, from these preliminary studies it appears as if the astrocytes 
play an important part for the barrier integrity, both in health and disease.   
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7.4 Ethical reflection 
One of the largest dilemmas today is that new drugs fail in a late stage of 
development, as there are few testing models for earlier stages of development 
capable of faithfully replicating the complex structure and environment of an 
organ. Organs-on-chip models have been developed in order to create more 
reliable in vitro models compared to the commonly used static models, such as 
the Transwell setup. However, the BBB-on-chip models that exist today are still 
far from fully mimicking the very complex structure of the BBB and the NVU. As 
such, in vivo models are, and will continue to be, important models used for drug 
development and research. What the BBB-on-chip models can contribute with is 
more reliable early stage tests prior to in vivo tests, which would hopefully 
decrease the unnecessary use and suffering of animals.   
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8 Conclusion and recommendations 
In this study the aim was to evaluate the influence on astrocytes and their culture 
environment on BBB modeling in a microfluidic chip. The project was divided 
into three experiments: culture astrocytes in different hydrogel compositions and 
evaluate the influence on the cells, incorporate a stable hydrogel in a microfluidic 
chip and in the final experiment establish a co-culture system with endothelial 
cells and astrocytes and measure the influence of astrocytes in the barrier 
integrity.  
Astrocytes were cultured in different hydrogels and the results from this study 
indicate that there are significant differences in reactivity between astrocytes, 
although the results seem to correlate more with gel stiffness then the addition of 
HA. Hydrogels containing astrocytes distributed throughout the height of the gel 
were successfully incorporated in microfluidic channels with high attachment to 
channel walls. In the final experiment where the effects of a co-culture system 
were to be evaluated, there was no formation of a barrier due to decreased 
viability of the endothelial cells. The hydrogels that were incorporated in the chip 
failed after a few days in the chip with a varying viability of astrocytes inside the 
gels. These results indicate that the current chip design may not be suitable for the 
co-culture system applied in this study.   
8.1 Future recommendations 
The prospects of a co-culture system in a microfluidic chip are promising, 
however there are a few things that should be considered before implementing 
one. 
First of all the incorporation of a hydrogel in the chip design used for these 
experiments should be optimized. Due to material properties of the chip the 
surface needs to be treated before interactions are achieved that are strong enough 
to maintain the structure of the hydrogel. Another complication with the current 
design is the incorporation of air bubbles in the chips, most likely due to the 
electrode compartment. If good solutions are found to address these two problems 
the current chip design can be used. However, another idea is to alter the chip 
design. If a suitable design is found this may be a better idea in order to decrease 
the risk of gel failure in the chip. One strong suggestion is to incorporate a 
medium channel, both to decrease the forces applied to the gel, but also to 
decrease the time of flushing the chip.  
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One of the main focuses in this report is the effect of culturing environment on 
astrocytes. From literature there are strong suggestions that the culture conditions 
have an important influence on astrocyte reactivity and morphology, especially 
comparing 2D and 3D cultures. The reactive state of astrocytes is reported to 
decrease the BBB integrity, it is important to evaluate the reactivity of the 
astrocytes used for BBB modeling. The commonly used astrocyte marker, GFAP, 
is upregulated during the reactive state of astrocytes making the evaluation of 
reactivity relatively easy to include in the evaluation of the model. 
To measure GFAP expression the cells are often stained with antibodies and the 
intensity evaluated through image analysis. In order to ensure proper staining of 
the astrocytes and to avoid background noise that may limit the detection of lower 
expression levels, an optimization of the staining protocol should be performed. 
The recommendation is to test different dilutions of the staining in the system to 
be used. Especially when working with hydrogels the staining and washing steps 
will need different incubation times depending on the flushing method and the 
thickness of the gel. Another thing to consider is the use of a blocking buffer 
specific for the antibodies applied. For evaluation of intensity levels a suitable 
image analysis method for the system should be established. Since a high number 
of cells should be analyzed in order to get statistically relevant results the method 
should preferably be carried out automatically. Some problems that needs to 
addressed for a successful method is the handling of out-of-plane cells and 
background noise. If possible, 3D imaging with a confocal microscope should be 
considered.    
The final recommendation is about the co-culturing of endothelial cells and 
astrocytes. There are several reports of increased barrier tightness after addition of 
astrocytes to the barrier. However, it is important to be aware that the influence 
varies between cell lines. Especially for hCMEC/D3, which is the cell line used in 
this study, the influence of astrocytes on the barrier tightness is reported to not be 
very large, although an increase has been reported. It is important to not only 
evaluate if astrocytes will increase the barrier tightness, but also to evaluate the 
effect of reactive astrocytes on the barrier physiology. There are a few studies 
where agents are added to increase the reactivity of astrocytes while measuring 
the effect on the barrier through TEER measurements. Nevertheless, due to the 
differences between cell lines further investigation of this is needed.  
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Appendix 
A. Protocols 
Chip fabrication 
PDMS base agent was mixed with the curing agent at a 10:1 wt ratio (Sylgard 184 
Silicone elastomer kit, Dow Corning). The mix was degassed in vacuum for 1.5 h 
to remove air bubbles. A wafer with the desired chip design (prepared with a SU-
8 mold fabrication process) was cleaned with an air blow gun and covered with 
PDMS, degassed for another 30 min and then baked in the oven at 60
ᵒ
C for at 
least 4 hours. When done baking, the PDMS mold was carefully removed from 
the wafer and cut into chips using a razorblade. The holes accessing the channels 
were made in the top parts of the chips with a 1 mm biopsy punch (Integra 
Miltex). In order to keep the chips clean they were covered with Scotch tape 
(3M). For the experiments two different chip designs were used and in the 
following sections the assembly of these chips will be described in further detail.  
A single-channel PDMS chip with one inlet and one outlet was bonded to a glass 
cover slip coated with PDMS. Prior to bonding of the chip to a glass cover slip 
(24mm 
. 
40 mm, Knittel Glass) the glass cover slip was coated with a thin layer of 
PDMS by adding 200 µl of PDMS and spin-coating it for 180 s at 6000 rpm (Spin 
150, Polos, the Netherlands). The PDMS was made the same way as for the chips 
and degassed prior to use. The glass cover slips covered with PDMS were baked 
in the oven at 60
ᵒ
C for at least 2 h and then the chips and the glass slides were 
treated with oxygen plasma (Cute, Femto Science). Directly after the plasma 
treatment chip and glass cover slips were bonded and left in room temperature for 
at least 24 h.  
A two-compartment PDMS chip contains two channels aligned perpendicular to 
each other with four inlets and outlets. In connection to each channel there are 
two electrode channels and a polycarbonate membrane separates the two 
channels. To connect the top part with the bottom part a glue was used made of 
PDMS and curing agent with a 10:1 wt ratio, mixed together with toluene 
(Merck) at a 5:3 wt ratio. Glue was applied to a glass cover slip and spin coated 
for 60 seconds at 1500 rpm. The glue was applied to the chip parts and a 
polycarbonate membrane (Transwell culture inserts, Corning Incorporated) was 
positioned over the middle of the channel prior to the alignment of the parts. As a 
last step the chips were baked in 60
ᵒ
C for 3 h [61].  
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Cell culturing 
For the culturing of astrocytes, primary human astrocytes were used (ScienCell 
Research Laboratories). They were grown in T75 flasks, either pre-coated with 
PLL (Sigma Aldrich) or without pre-coating (Cellstar). For the experiments cells 
at passage number of 4-9 were used. The cells were grown in astrocyte medium 
(AM: Gibco) and when passaged the cells were washed with PBS (Sigma), 
detached from the flask with 0.05% trypsin-EDTA (Gibco) and after 5 min of 
incubation at 37
ᵒ
C in humidified air containing 5% CO2, RPMI+ (RPMI medium, 
fetal bovine serum (10% of the total volume), Penicillin Streptomycin and L-
glutamine; Gibco) was added to deactivate the trypsin-EDTA. The suspension 
was centrifuged at 390g for 5 min and the cell pellet was re-suspended in new 
medium. The cells were either subcultured in a new flask or used for experiments. 
For brain endothelium, the hCMEC/D3 cell line was used for these experiments. 
They were grown in T75 flasks, pre-coated with fibronectin or collagen type I 
(Cellcoat). For the experiments in this report cells at a passage number of 34 and 
35 were used and they were grown in EGM-2 (EBM-2 with EGM-2 SingleQuots, 
Lonza).  
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Hydrogels 
In all experiments hydrogels were made at different concentrations and 
components. All the volumes added of each component for the three experiments 
have been summarized in Table 4. 
Table 4. Table summarizing the concentrations and volumes used to make the hydrogels in the three 
experiments. In experiment three, four different tubes with the exact same volumes were made to 
decrease the risk of early gelling in the tube, and therefore the volumes used for only one tube is 
presented in the table.  C- collagen type I and HA- hyaluronic acid. 
 Exp 1 Exp 2 Exp 2 Exp 2 Exp 2 Exp 2 Exp 3 
Condition C 3   C 4  C:HA 
3:1 
C:HA 
4:1 
C:HA 
5:1 
C:HA 
4:2 
C:HA 
3:1 
Collagen 
stock 
(mg/ml) 
9.66 8.56 8.56 8.56 8.56 8.56 8.56 
HA stock 
(mg/ml) 
- - 10 10 10 10 10 
Total 
volume (µl) 
300 150 150 150 150 150 200 
10 X PBS 
(µl) 
10 7.78 5.84 7.78 9.73 7.78 7.8 
1 M NaOH 
(µl) 
2.1 1.6 1.2 1.6 2 1.6 1.6 
Collagen 
type I (µl) 
93 70 52.6 70 87.6 70 70 
HA (µl) - - 15 15 15 30 20 
PEGDA (µl) - - 3.75 3.75 3.75 7.5 5 
Cells in AM 
(µl) 
195 70.62 71.61 51.87 31.92 33.12 95.6 
 
Staining of cells 
Fixation of the cells was carried out by removing medium from the system by 
flushing twice with PBS. The flushing step was performed by leaving a pipette tip 
with 100 µl of PBS connected to the inlet for 30-60 min. If carried out in a wells 
plate the medium was removed by pipetting and PBS was added for 15 min. A 
3.7-4% (para)formaldehyde solution was added in order to fixate the cells and the 
samples were incubated with the solution at room temperature for 30-60 min. 
Afterwards they were washed three times with PBS for 30-60 min and stored 
covered in PBS at 4
ᵒ
C until staining.  
88 
 
Staining in 2D 
When staining with antibodies, the primary antibody was diluted in 0.1% (v/v) 
Triton-X 100 (Sigma Aldrich) and 1% (m/m) bovine serum albumin (BSA: Sigma 
Aldrich) in PBS and the fixated cells were incubated in the solution overnight at 
4
ᵒ
C (rat anti-GFAP 1:50 (Invitrogen)). The cells were flushed with PBS three 
times and afterwards incubated with the diluted secondary antibody and 
additional stainings in Triton-X 0.01% + BSA for 1 hour (goat anti-rat IgG Alexa 
Flour 488 1:100 (Invitrogen); goat anti-rat IgG Alexa Flour 568 1:100 (Molecular 
probes, Life Technologies); NucBlue 2 drops/mL (Molecular Probes, Life 
Technologies); ActinGreen 2 drops/mL (Molecular Probes, Life Technologies); 
Texas Red-X Phalloidin 1:40 (Invitrogen)). In the final step the cells were washed 
three times with PBS.   
Staining in hydrogel 
When staining with antibodies, the primary antibody was diluted in 0.1% Triton-
X and 1% BSA and the gels were incubated in the solution overnight at 4
ᵒ
C (rat 
anti-GFAP 1:50). The gels were flushed with PBS for at least 6 hours, changing 
the pipette tips (containing 100µl only added to the inlet) every hour. Afterwards, 
the samples were incubated with the diluted secondary antibody and additional 
stainings in 0.1% Triton-X and 1% BSA overnight at room temperature or 4
ᵒ
C 
(goat anti-rat IgG Alexa Flour 488 1:100; goat anti-rat IgG Alexa Flour 568 
1:100; NucBlue 2 drops/mL; ActinGreen 2 drops/mL; Texas Red-X Phalloidin 
1:40). In the final step the gels were flushed with PBS for at least 6 h, changing 
the pipette tips every hour.   
Microscopy 
For phase contrast imaging and fluorescence imaging the EVOS FL Cell Imaging 
System microscope was used (Life Technologies). Four fluorescent filter cubes 
were applied depending on staining; green (GFP) with excitation wavelength of 
470/22 nm and emission wavelength of 525/50 nm, blue (DAPI) with an 
excitation wavelength of 357/44 nm and emission wavelength of 447/60 nm, red 
(RFP) with an excitation wavelength of 531/40 nm and emission wavelength of 
593/40 nm and infra-red (CY5) with an excitation wavelength of 628/40 nm and 
emission wavelength of 685/40 nm (Life Technologies).  
To obtain three dimensional images a Nikon Confocal A1 microscope was used. 
For the samples mentioned in this report excitation lasers with wavelengths of 
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405 nm for emission of blue light and 488 nm for emission of green light were 
used.  
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B. Hydrogel composition in chips 
Materials and methods 
A total of 12 chips and two wells in a 96 wells plate were used for the experiment. 
A chip design with a PDMS chip containing a single channel attached to a PDMS 
covered glass cover slip was used (see appendix A. Chip fabrication). The 
surfaces of the channels were treated with APTES and GA prior to adding the 
gels (for protocol, see section 4.1).  
Five different gel concentrations with varying collagen type I and HA 
concentrations were tested together with controls for the staining: astrocytes 
seeded in 2D for positive control and endothelial cells seeded in a hydrogel for 
negative control. All conditions are summarized in Table 5. Astrocytes at a 
passage number of 9 and endothelial cells at a passage number of 35 were used. A 
fixed cell concentration of 2.5
.
10
5
 cells/ml was used for all the chips while 
hydrogel concentrations were varied. 
Table 5. Table summarizing the 7 different conditions used in the experiment. In condition 1 
astrocytes were seeded in a collagen type I gel was used as a positive control. In conditions 2-5 
astrocytes were seeded in gels where the concentrations of collagen type I and HA were varied. 
Condition 6 has endothelial cells seeded in a collagen type I gel for negative control, and in the final 
condition astrocytes are cultured in 2D in wells plates. A – astrocytes, E – endothelial cells and W – 
wells plate. 
Condition 1 2 3 4 5 6 7 
Cell type A A A A A E A 
Collagen 
concentration 
(mg/ml) 
4 3 4 5 4 4 0 
HA 
concentration 
(mg/ml) 
0 1 1 1 2 0 0 
Chip number 1 2 3 4 5 6 7 8 9 10 11 12 W W 
 
All the gels were made according to the following protocol with varying volumes 
depending on the condition. 10X PBS, 1M NaOH and AM were added to 
Eppendorf tubes and put on ice. Afterwards, the collagen type I and HA mixed 
with poly(ethylene glycol) diacrylate (PEGDA; Glycosan HyStem Trial Kit) at a 
ratio of 1:4 was added, according to manufacturer’s recommendations. In the final 
step the cells were detached from the culture flasks and resuspended in AM or 
EGM-2 and added to the Eppendorf tubes. After mixing of the liquid gel through 
pipetting, it was added to the chips. The gels were left to incubate at 37
ᵒ
C for 30 
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min in order to gel, before 100 µl of medium was added to the inlet of the 
channel, and an empty pipette tip to the outlet. In two wells of a 96 wells plate 
astrocytes were seeded at a concentration of 2.0
.
10
4
 cells/cm
2
.  
Medium was refreshed twice per day during the 48 h that the experiment lasted 
for and time frames were taken of the cells after 4 h, 24 h and 48 h with phase 
contrast microscopy. After 48 h the cells were fixated and stained with 
ActinGreen, NucBlue, primary antibody rat anti-GFAP and secondary antibody 
goat anti-rat IgG Alexa Fluor 568 according to protocols in appendix A. Staining 
of cells, and imaged with fluorescent microscopy. 
Results and discussion 
In the experiment a total of 12 chips were filled with cells seeded in different 
hydrogel compositions. Furthermore, two wells in a 96 well plate were seeded 
with astrocytes directly on the bottom of the well. All chips were successfully 
filled, only in one chip an air bubble was incorporated close to the inlet which 
caused the flow in the chip to be blocked. In three chips the gel detached from the 
walls and these were not stained. In Table 6 the different conditions and the 
results from the chips prior to staining are shown. 
Table 6. Summary of the conditions of the chips after the experiment was finished. S – staining, D – 
detached gel and X – damage to chip. 
Condition 1 2 3 4 5 6 
Chip number 1 2 3 4 5 6 7 8 9 10 11 12 
48 h S S D S S S D S X S S D 
 
After the 48 h duration of the experiment the cells were stained and from the 
staining it was shown that the viability in the chips was very low. There were a 
few cells that had short and few processes and some expressed GFAP, as can be 
seen in Figure 40.  
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Figure 40. Image from chip 1 where few astrocytes with processes are visible. Image taken with 
fluorescent microscopy using GFP and DAPI filter. Scale bar is 200 µm.  
 
From images taken at the three different time frames of 4, 24 and 48 h, see Figure 
41-43, living cells with spread out processes are seen at 4 h, while at 48 h very 
few viable cells with the typical morphology are visible, implicating that the 
viability of the cells decreased after the cells had been added to the chips.   
 
Figure 41. Image of the 
channel in chip 10, 4 h after 
the gel had been added. Viable 
cells with spread out processes 
are visible. Taken with phase 
contrast microscopy and scale 
bar is 200 µm. 
 
Figure 42. Image of the 
channel in chip 10, 24 h after 
the gel had been added. Few 
viable cells with spread out 
processes are visible. Taken 
with phase contrast microscopy 
and scale bar is 200 µm. 
 
Figure 43. Image of the 
channel in chip 10, 48 h after 
the gel had been added. Barely 
any viable cells with spread out 
processes are visible. Taken 
with phase contrast microscopy 
and scale bar is 200 µm. 
 
A cause for the decreased viability in the chip was first hypothesized to be 
nutrition deficiency. However, after some further consideration another 
suggestion was that the low cell concentration together with a high medium flow 
could be the cause for the decreased viability. The difference in this experiment in 
comparison to the one with surface treatment was that the cell concentration was 
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lowered and the method of changing medium was changed. In the prior 
experiment a pipette tip with 150 µl was inserted in the inlet and 100 µl in the 
outlet, while in this experiment the medium was changed by a pipette tip with 100 
µl in the inlet and an empty pipette tip in the outlet. A higher flow will mean that 
the cells will be exposed to higher forces. There is also a risk that the flow flushes 
away signaling molecules that due to the low cell concentration are present in low 
concentrations. This unfamiliar environment for the astrocytes may cause the 
decreased viability. However, to confirm this hypothesis further investigation is 
needed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
